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Abstract
The neural precursor cell expressed developmentally down-regulated gene 4 (NEDD4) is a HECT-type E3
ubiquitin ligase that has received broad attention in recent years. Many of its reported substrates are
active players in metabolism, implying a potential role of NEDD4 itself in metabolic regulation. Since
homozygous Nedd4 deletion leads to embryonic or perinatal lethality, we investigated the function of
NEDD4 in metabolic regulation in vivo, using Nedd4- haploinsufficient mice in a high fat diet-induced
obesity (HFDIO) model.
Our studies show that Nedd4-haploinsufficient mice fed a normal diet (ND) exhibited decreased body
weight in both genders and proportionally reduced tissue mass compared to their age-matched wild-type
littermates. The heterozygotic Nedd4-deficient mice displayed moderate insulin resistance and mild
hyperinsulinemia. These findings are consistent with others’ studies in which depletion of Nedd4 in
mouse embryonic fibroblasts (MEFs) led to a decline in insulinlike growth factor I (IGF-1) and insulin
signaling.
Surprisingly, Nedd4-haploinsufficient mice were partially protected against high-fat diet (HFD) induced
obesity. Total weight gain was decreased by 30% in Nedd4-haploinsufficient mice on HFD, which was
associated with reduced adiposity, improved insulin sensitivity in white adipose tissue (WAT), alleviated
hepatic steatosis and attenuated lipid-induced inflammation. NEDD4 reduction did not affect serum
glucose or lipid profile. The energy intake and physical activity were almost indistinguishable between the
two groups. We present data indicating that these beneficial effects of Nedd4 haploinsufficiency under
conditions promoting obesity or type 2 diabetes (T2D) derive from at least two mechanisms: 1) elevated
levels of β- agonist induced lipolysis through stimulation of β-adrenergic signaling as evidenced by
enhanced β2 adrenergic receptor (β2-AR) cell surface levels; 2) repressed expression of a key adipogenic
regulator, peroxisome proliferator-activated receptor gamma (PPARγ) in Nedd4- haploinsufficient mice in
the WAT. Downregulation of NEDD4 in 3T3-L1 preadipocytes impaired the adipogenic response, resulting
in decreased PPARγ expression. Thus, the reduced adiposity in Nedd4-haploinsufficient mice fed a HFD
compared to littermate wild-type mice may be explained at least in part by their increased lipolysis and
suppressed adipogenesis. Our data also imply that NEDD4 may have differential functions in modulating
insulin signaling under physiological and pathological conditions.
In this study, we tested the possible impact of NEDD4 reduction on cognitive function and anxiety
behaviors. Preliminary results showed that Nedd4-haploinsufficient mice had impaired learning and
memory performance but increased anxiety compared to wild-type littermates. NEDD4 may modulate
different behavioral functions by targeting specific substrates for protein degradation in a brain-regionspecific manner. Precise substrates that cause the alteration in such behaviors are yet to be determined
by future studies.
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ABSTRACT
The neural precursor cell expressed developmentally down-regulated gene 4
(NEDD4) is a HECT-type E3 ubiquitin ligase that has received broad attention in recent
years. Many of its reported substrates are active players in metabolism, implying a
potential role of NEDD4 itself in metabolic regulation. Since homozygous Nedd4
deletion leads to embryonic or perinatal lethality, we investigated the function of NEDD4
in metabolic regulation in vivo, using Nedd4-haploinsufficient mice in a high fat dietinduced obesity (HFDIO) model.
Our studies show that Nedd4-haploinsufficient mice fed a normal diet (ND)
exhibited decreased body weight in both genders and proportionally reduced tissue mass
compared to their age-matched wild-type littermates. The heterozygotic Nedd4-deficient
mice displayed moderate insulin resistance and mild hyperinsulinemia. These findings
are consistent with others’ studies in which depletion of Nedd4 in mouse embryonic
fibroblasts (MEFs) led to a decline in insulin-like growth factor I (IGF-1) and insulin
signaling.
Surprisingly, Nedd4-haploinsufficient mice were partially protected against highfat diet (HFD) induced obesity. Total weight gain was decreased by 30% in Nedd4haploinsufficient mice on HFD, which was associated with reduced adiposity, improved
insulin sensitivity in white adipose tissue (WAT), alleviated hepatic steatosis and
attenuated lipid-induced inflammation. NEDD4 reduction did not affect serum glucose or
lipid profile. The energy intake and physical activity were almost indistinguishable
between the two groups. We present data indicating that these beneficial effects of Nedd4
haploinsufficiency under conditions promoting obesity or type 2 diabetes (T2D) derive
from at least two mechanisms: 1) elevated levels of ȕ-agonist induced lipolysis through
stimulation of ȕ-adrenergic signaling as evidenced by enhanced ȕ adrenergic receptor
ȕ2-AR) cell surface levels; 2) repressed expression of a key adipogenic regulator,
peroxisome proliferator-activated receptor gamma (PPARȖ) in Nedd4-haploinsufficient
mice in the WAT. Downregulation of NEDD4 in 3T3-L1 preadipocytes impaired the
adipogenic response, resulting in decreased PPARȖ expression. Thus, the reduced
adiposity in Nedd4-haploinsufficient mice fed a HFD compared to littermate wild-type
mice may be explained at least in part by their increased lipolysis and suppressed
adipogenesis. Our data also imply that NEDD4 may have differential functions in
modulating insulin signaling under physiological and pathological conditions.
In this study, we tested the possible impact of NEDD4 reduction on cognitive
function and anxiety behaviors. Preliminary results showed that Nedd4-haploinsufficient
mice had impaired learning and memory performance but increased anxiety compared to
wild-type littermates. NEDD4 may modulate different behavioral functions by targeting
specific substrates for protein degradation in a brain-region-specific manner. Precise
substrates that cause the alteration in such behaviors are yet to be determined by future
studies.
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CHAPTER 1.

INTRODUCTION

1.1 Obesity
1.1.1 Facts
The World Health Organization (WHO) defines overweight and obesity as a state
of “abnormal or excessive fat accumulation” (WHO official website). According to the
statistics provided by the WHO, there are 500 million adults worldwide who are obese
with a body mass index (BMI) over 30 kg/m2 and one billion who are overweight with a
BMI over 25 kg/m2. The number of overweight children under the age of five is
escalating each year exceeding 40 million in 2012 (Ogden et al., 2012). A survey
conducted by the United States Centers for Disease Control and Prevention (USCDC)
shows that Tennessee is among the states with highest obesity incident rate, having a
prevalence greater than 30% (2008) .
Increasingly recognized as disorders in their own right, being overweight or obese
certainly adversely affects individual’s quality of life. Moreover, an emerging body of
scientific, medical, and behavioral studies suggest raised body fat as a major risk factor
for the development of metabolic syndrome, T2D, cardiovascular disease (mainly heart
disease and stroke), and certain types of cancer. In the United States alone, obesity and its
complications contribute to over 300,000 premature deaths each year, making it the
second preventable cause of death behind tobacco smoking (Mokdad et al., 2004).
1.1.2 Etiology
Causes of obesity include genetic predisposition, environmental and
psychological factors. However, ultimately, obesity is a consequence of chronic
imbalance between energy intake and output. In certain cases, energy required for growth
and energy utilized for basic metabolic processes also account for the energy balance.
When energy intake exceeds energy output, a state of positive energy balance occurs,
thereby increasing body weight (Hill et al., 2012). After linear growth in early adulthood
energy balance becomes determined by three basic components: energy intake, energy
output, and energy storage (Hill et al., 2003).
Humans absorb energy in the forms of protein, carbohydrate and fat. Humans
expend energy primarily through basal metabolic rate, physical activity, and diet-induced
thermogenesis. The basal metabolic rate is the rate of energy expenditure at rest, which is
proportional to body mass and depends essentially on the lean mass (mostly the muscles)
(White and Seymour, 2003). The basal metabolic rate represents 60-70% of the total
energy output (Blundell et al., 2012). The energy expended through physical activity
varies and accounts for 20-30% of total energy output (Rising et al., 1994). Diet-induced
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thermogenesis is an increase in metabolic rate that occurs after eating, representing
approximately 10% of the total energy output (Tappy et al., 1991).
1.1.2.1 Genetic Factors. Genetic factors may cause changes in energy intake. For
example, mutations in leptin (Montague et al., 1997; Strobel et al., 1998), its receptor
(Clement et al., 1998), or mutations in melanocortin receptor 4 (Vaisse et al., 1998; Yeo
et al., 1998), proopiomelanocortin (Krude et al., 1998) and prohormone convertase 1
(Jackson et al., 1997) lead to pronounced hyperphagia and obesity. Energy expenditure
and energy storage can be regulated by genetic factors as well. For example, mutations in
uncoupling protein-2 (Fleury et al., 1997), acyl CoA:diacylglycerol transferase (Smith et
al., 2000), perilipin (Martinez-Botas et al., 2000), or cell death activator (cidea) (Zhou et
al., 2003) can lead to corresponding metabolic modifications. Recent genome wide
association studies and bioinformatics analysis have identified numerous single
nucleotide polymorphisms (SNPs) and loci which are strongly associated with body
fatness. Many of these SNPs lay within introns or even in the noncoding regions. Though
many monogenic effects have been identified, multiple subtle variants in genes are likely
to contribute to the common forms of human obesity, as is the case with T2D (Farooqi
and O'Rahilly, 2007).
1.1.2.2 Environmental Factors. Contemporary environments are filled with
readily available, inexpensive foods with high calorie content facilitating obesity.
Advanced technology and transportation systems promote sedentary life styles which are
frequently linked to the epidemic of obesity (Hill and Peters, 1998).
1.1.2.3 Psychological Factors. Obesity can be caused by psychological factors as
well. People with psychological disorders (e.g. depression, anxiety, low self-esteem, or
other emotions) may eat aberrantly, exercise insufficiently, and therefore, are more likely
to develop obesity (Stice et al., 2005).
1.1.3 Treatments
Balanced eating and healthy lifestyle are important strategies for weight loss and
maintenance. Weight loss helps improve overall health and reduce risk of developing
cardiovascular complications. For treatment of obesity, the commercially available drugs
mainly act through two mechanisms: reduce fat absorption through inhibition of gastric
and pancreatic lipases (e.g. orlistat (Curran and Scott, 2004)) and suppress appetite (e.g.
phentermine/ topiramate and lorcaserin (Fleming et al., 2013)).
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1.2 Adipose Tissue and Obesity
Adipose tissue is the main storage site for excess energy in the form of
triglycerides (TGs). Besides its storage function, adipose tissue also serves as an
endocrine organ, which is able to secrete a variety of cytokines, including leptin. Adipose
tissue is emerging as an important component in metabolism. An adipocentric view even
considers adipose as a determinant factor for insulin resistance. Indeed, excessive adipose
tissue increases the risk for the development of insulin resistance. Surprisingly, a lack of
adipose tissue in the body, for example in the case of Berardinelli-Seip congenital
lipodystrophy, in which fats are stored at ectopic sites in the body, such as in the liver and
muscles, can also lead to severe insulin resistance (Magre et al., 2001). A transgenic
model of inducible lipoatrophy provides consistent evidence (Pajvani et al., 2005).While
these observations seem paradoxical at first sight, they imply that proper function of
adipose tissue is critical for maintaining whole-body insulin sensitivity. A brief
introduction to the concepts of insulin action and insulin resistance is necessary in order
to understand these observations.
1.2.1 Insulin Action in Adipose Tissue
Insulin is a small molecule of 51-residue and with a molecular weight of
approximately 6 kilodalton (kDa). It is produced by the pancreatic ȕFHOOV, when amino
acids or glucose levels are increased in the bloodstream. Tissues that are responsive to
insulin action are referred to as insulin-sensitive tissues, which include but are not limited
to skeletal muscle, liver, fat and hypothalamus.
The cellular insulin signaling event initiates from the membrane-localized insulin
receptor (IR), which belongs to the family of receptor tyrosine kinases (RTKs). The IR is
DKHWHURWHWUDPHUFRQVLVWLQJRIWZRĮ-VXEXQLWVDQGWZRȕ-subunits held together by
disulfide and noncovalent bonds (Lee and Pilch, 1994). IR undergoes glycosylation
before its insertion to the plasma membrane. Both subunits are exposed to the
extracellular environment, while only the C-terminal ȕ-subunit is intracellular (Lee and
Pilch, 1994). Following ligand binding, the ȕ-subunit undergoes autophosphorylation on
seven Tyr residues in a sequential order and a conformational change that further
increases kinase activity. The three most critical tyrosine sites are Tyr 1158, 1162 and
1163, phosphorylation of which results in activation of the receptor kinase activity
(Feener et al., 1993; Hubbard, 1997). Subsequently, the activated IR phosphorylates a
number of intracellular substrates on tyrosine. The primary substrates are the members of
the insulin receptor substrate family (IRS1/2/3/4). Other substrates include: Srchomology-2-containing protein (Shc), IRS-5 and IRS-6 (or DOK-4 and DOK-5), Cas-BrM (murine) ectopic retroviral transforming sequence homologue (Cbl), Cbl-associated
protein (CAP), signal transducer and activator of transcription (STAT) and GRB2associated-binding protein 1 (Gab-1), and p62dok (Cai et al., 2003; Lehr et al., 2000;
Taniguchi et al., 2006; Wick et al., 2001).
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Following phosphorylation, these substrates serve as important intermediates that
interact with other intracellular molecules. For example, tyrosine phosphorylation of IRS
proteins creates recognition sites for other proteins containing Src homology 2 (SH2)
domains, most notably, the p85 regulatory subunit of the phosphatidylinositol 3–kinase
(PI3K) which activates AKT/protein kinase B (PKB) by catalyzing the production of
phosphatidylinositol-3,4,5-triphosphate (PIP3) from phosphatidylinositol 4,5bisphosphate (PIP2) at the plasma membrane (Taniguchi et al., 2006). This eventually
promotes the two main downstream signaling pathways: the PI3K-AKT/PKB pathway
and the Ras–mitogen-activated protein kinase (Ras-MAPK) pathway. The former
pathway mediates most of insulin's metabolic actions, while the latter pathway regulates
general gene expressions for cell growth, survival, and differentiation (Taniguchi et al.,
2006).
PI3K is necessary for insulin-stimulated glucose transport via AKT/PKB (Wang
et al., 1999b) and/or the atypical protein kinase C (PKC) LVRIRUPȜȗ(Kotani et al., 1998),
whereas another pathway involving the Cbl-CAP complex is also implicated for the
translocation of glucose transporter type 4 (GLUT4) protein from intracellular sites to the
cell surface of the membrane (Chiang et al., 2001).Besides stimulation of glucose uptake,
insulin is also known to be an important antilipolytic hormone in adipose tissue. Insulin
exerts its antilipolytic effect through inducing phosphorylation and activation of the
phosphodiesterase type 3B (PDE3B), which is dependent on the activation of PI3K/AKT
pathway (Kitamura et al., 1999; Rondinone et al., 2000). Activation of PDE3B decreases
concentrations of adenosine 3’,5’-monophosphate (cAMP), which in turn reduces the
activity of protein kinase A (PKA), a cAMP-dependent protein kinase (Degerman et al.,
1997). PKA is responsible for activation of two important proteins with established
function in lipolysis: the hormone-sensitive lipase (HSL), an enzyme that catabolizes TGs
in adipocytes, and perilipin A, a protein that associates with the surface of lipid droplets
and the phosphorylation of which is required for lipid droplet mobilization (Zimmermann
et al., 2004). It should be noted those insulin concentrations required for its antilipolytic
effect are lower than that required for its glucose uptake effect. Hence, even under insulin
resistant conditions when the insulin-stimulated glucose uptake is impaired, its
antilipolytic effect maintains the growth of adipose tissue (Kahn and Flier, 2000). In
addition, insulin serves as a potent pro-adipogenic hormone that triggers the expression
of a series of transcription factors facilitating the conversion from pre-adipocytes to
mature adipocytes (Rosen and MacDougald, 2006).
1.2.2 Insulin Resistance in Adipose Tissue
Insulin resistance is a physiological state where the body fails to respond
adequately to insulin. This is manifested by reduced glucose uptake in adipocytes and
skeletal muscle and by diminished suppression of hepatic glucose production. In the
1930s, Dr. H.P. Himsworth was the first to distinguish insulin resistance from insulin
deficiency (Himsworth, 1940). He found that some diabetic individuals (typically lean
and with early-onset diabetes) could rapidly respond to the injection of insulin, while
some others (obese and with later-onset diabetes) could not. Following this track, in the
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1960s, Dr. D. Rabinowitz and K.L. Zierler discovered that some obese but non-diabetic
individuals were also resistant to the effects of insulin (Rabinowitz and Zierler, 1961). An
extensive clinical study in 1990s provided the most direct evidence that the insulin
sensitivity index is negatively correlated with abdominal fatness in both men and women
(Clausen et al., 1996). Normally, the more fat tissue one has the more resistant his or her
cells respond to insulin. Therefore, insulin resistance is commonly seen coexisting with
obesity. It is now well accepted that obesity-associated insulin resistance is the major
mechanistic basis for the link between obesity and many other metabolic diseases, such
as T2D and cardiovascular disease (Kahn and Flier, 2000).
Insulin resistance in obesity is hypothesized to be caused by defects at multiple
levels of insulin signaling, increased amount of non-esterified fatty acids (NEFAs), also
referred to as free fatty acids (FFAs), released from adipose tissue and changed adipokine
profile.
1.2.2.1 Defects in Insulin Signaling. Several lines of evidence suggest that
insulin signaling in insulin-responsive tissues is impaired in obesity. In skeletal muscles
from obese humans, expression of several insulin signaling molecules was decreased
(Goodyear et al., 1995). In obese humans with T2D, IRS-1 expression was found to be
reduced in adipocytes (Rondinone et al., 1997), and PI3K activity was attenuated in both
adipocytes and skeletal muscles (Kim et al., 1999; Rondinone et al., 1997). Mice double
knockouts of IRS-1 and IRS-3 exhibited a severe phenotype: severe lipoatrophy at early
stage and insulin resistance (Laustsen et al., 2002). The expression and activity of several
protein tyrosine phosphatases (PTPs), such as PTP1B and src-homology-containingphosphatase 2 (SHP-2) were increased in skeletal muscle and adipose tissue in obese
humans and rodents (Goldstein et al., 1998). PTPs are negative regulators of insulin
signaling by dephosphorylating IR. In agreement, PTP1B knockout mice had increased
insulin sensitivity and resistance to diet-induced obesity (Elchebly et al., 1999; Klaman et
al., 2000).
Surprisingly, the fat insulin receptor knockout (FIRKO) mice displayed improved
metabolic outcomes compared to wild-type mice (Bluher et al., 2002). When the mice
were fed with a high-fat diet (HFD) or were treated with gold thioglucose, which caused
hypothalamic damage and hyperphagia, the beneficial effects of the loss of insulin
signaling in fat became even more significant. The FIRKO mice had reduced fat mass.
They were protected against obesity and its associated glucose intolerance (Bluher et al.,
2003; Bluher et al., 2002). Moreover, both male and female FIRKO mice had an increase
in average life-spans (Bluher et al., 2003). Therefore, reduced insulin signaling in
adipocytes, nonetheless, appears to prevent the development of obesity and its associated
metabolic abnormalities.
1.2.2.2 Increased Release of FFAs. Elevated FFA concentrations in obesity are
thought to arise from the expanded adipose tissue. FFA has long been recognized as an
energy source for other tissues. An additional function of FFA as an endocrine factor that
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regulates metabolic functions has been proposed since 1960s (Kennedy, 1992).Moreover,
FFA has been proposed as a major culprit for insulin resistance: under insulin resistant
state, lipolysis in adipocyte which is normally suppressed by insulin, is further increased,
thereby liberating more FFA and in turn aggravating insulin resistance. In this model,
elevated FFA levels are demonstrated to lead to intracellular accumulation of several
metabolites including acyl-CoAs, ceramides, and diacyglycerol (DAG), which can
activate protein kinases such as PKC, c-Jun N-terminal kinases (JNKs), and the inhibitor
of nuclear factor-ț% 1)-ț% NLQDVH-ȕ ,..ȕ 7KHVHNLnases in turn increases the
inhibitory serine phosphorylation of IRS1/2 (Petersen and Shulman, 2006).
However, this concept has now been questioned. In a clinical study involving a
prospective cohort of 481 women and 345 men, the fasting FFA concentrations did not
predict the development of insulin resistance (Byrne et al., 1999). In the Karpe et al.
study, in which 43 original reports including a total number of 953 non-obese (control)
patients and 1,410 overweight/obese patients were pooled and reanalyzed in aggregates
by literature search from PubMed and were aligned for a relationship between the fasting
FFA concentration and the fat mass. Surprisingly, the result clearly showed a complete
absence of relationship between adipose tissue mass and the fasting FFA concentration
(Karpe et al., 2011). Therefore, whether the elevated FFA levels truly contribute to the
pathogenesis of obesity-associated insulin resistance remains an open question.
1.2.2.3 Changed Adipokine Profile. The profile of adipokines secreted from
adipose tissue also undergoes major changes in obesity. Release of most adipokines is
elevated in obesity, including the metabolically beneficial hormone leptin (Sinha et al.,
1996). Leptin signaling is concomitantly impaired in obesity(Jequier, 2002). Loss of
leptin produced severe obesity in a previous study (Montague et al., 1997). Resistin, an
adipocyte-secreted protein, was also found to circulate at high levels in the bloodstream
in obese rodents. Infusion or sustained overexpression of resistin caused insulin
resistance, while knocking out resistin in mice improved glucose metabolism (Steppan et
al., 2001). Conversely, adiponectin levels are low in obesity. The administration or
transgenic overexpression of adiponectin improved insulin resistance and lowered FFAs
in serum in animal models (Lihn et al., 2005). Consistently, adiponectin-deficient mice
developed insulin resistance and had increased serum FFAs (Lihn et al., 2005).
Highly upregulated adipokines in adipose tissue of obese subjects also include
several proinflammatory cytokines. For example, the plasma concentration of monocyte
chemoattractant protein 1 (MCP-1) was high in obese mouse models, leading to massive
macrophage infiltration and insulin resistance (Kanda et al., 2006). Other inflammationassociated cytokines released from macrophages or adipocytes are tumor necrosis factor
Į (71)Į), interleukin-1ȕ (IL-ȕ) and interleukin-6 (IL-6) (Qatanani and Lazar, 2007). It
has been proposed that cytokines released from adipose tissue induce a systemic lowgrade inflammation and promote insulin resistance (Xu et al., 2003).
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1.2.3 Lipid Storage and Mobilization in Adipose Tissue
Adipocytes synthesize TGs from circulating FFA pool. After a meal, circulating
dietary fat absorbed by the intestinal tract in the form of chylomicrons is hydrolyzed by
lipoprotein lipase (LPL) in the capillary endothelium in adipose tissue. FFAs thus
released are taken up into the adipocytes for storage. The endogenous TGs carried by
very low-density lipoprotein (VLDL) are removed by LPL from VLDL and taken up by
adipocytes via VLDL receptor (VLDL-R) or low density lipoprotein receptor-related
protein (LRP) for storage. FFAs can also be transported into adipocytes via a family of
fatty acid transport proteins (FATPs), such as FATP1 (Gimeno, 2007). Fatty acids are
transported by fatty acid binding proteins (FABPs) inside an adipocyte, notably the
FABP-4 (Maeda et al., 2005). After their entry, fatty acids are esterified by acyl-coA
synthetase. Esterified fatty acids together with glycerol are used for TG synthesis.
Alternatively, adipocytes can use acetyl-CoA for de novo fatty acid synthesis via acetylCoA carboxylase (ACC) and fatty acid synthase (FAS). TG are incorporated into lipid
droplets and covered by perilipin. The remnant FFAs and TG-rich lipoproteins that are
not taken up by the adipocytes are eventually taken up in ectopic sites, such as skeletal
muscles, liver, pancreas, and heart (Karpe et al., 2011).
FFAs are stored as TG in a highly dynamic fashion. When necessary, FFAs can
be re-released from fat. Break down of TGs to glycerol and FFAs is called lipolysis.
During energy deprivation (e.g. fasting and exercise), lipolysis is stimulated in adipocytes
and leads to the liberation of FFAs, which can be metabolized by other tissues, such as
muscle, for energy production via ȕ-oxidation (Duncan et al., 2007). The process of TG
hydrolysis is three steps: TG is first to form diacylglycerol (DAG) by adipose triglyceride
lipase (ATGL), then to monoacylglycerol (MAG) by HSL, and finally to FFAs and
glycerol by monoacylglycerol lipase (MGL). HSL is the rate-limiting as well as the
hormonally regulated step of this process. The lipolytic response is mainly controlled by
catecholamines (epinephrine and norepinephrine) and the fasting hormones glucagon, via
their binding to respective receptors, i.e. adrenergic receptors and glucagon receptors.
Both lead to activation of adenylate cylase by stimulatory guanine nucleotide regulatory
proteins (Gs) within the plasma membrane. Adenylate cyclase then enzymatically
converts ATP to cAMP, which in turn activates PKA by binding to its regulatory subunit
and releasing its catalytic subunit. Subsequently, the catalytic subunit of PKA
phosphorylates perilipin and HSL for fat mobilization (Figure 1.1). While fasting or
exercise enhance lipolysis, defective lipolysis was found in mature fat cells and in
differentiated preadipocytes isolated from obese and non-obese human (Langin et al.,
2005). Therefore, modulation of adipocyte lipolysis via pharmacological intervention
may be a promising therapeutic strategy for treating obesity.
1.2.4 Different Adipose Tissue Depots
Classically, there are two types of adipose tissues within body: white and brown.
It has long been believed that only newborns humans and rodents have interscapular
brown adipose tissue (BAT). However, several recent studies show that brown adipocytes
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Figure 1.1 /LSLG0HWDEROLVPLQ$GLSRF\WHE\ȕ-adrenergic and Insulin Signaling.
Adipocyte H[SUHVVDOOWKUHHȕ-AR subtypes—ȕ1ȕ2, and ȕ3. Catecholamine binds to the ȕAR and initiates a dissociation of GĮs from GȕȖ. GĮs stimulates the membrane
associated enzyme adenylate cyclase (AC) to promote the production of cAMP from ATP
and subsequently, activates PKA. Activated PKA phosphorylates both perilipin-1 and
HSL. Phosphorylated perilipin-1 releases 1-acylglycerol-3-phosphate O-acyltransferase
(ABHD5) (or CGI-58) to ATGL. Upon ABHD5 binding, ATGL is activated and initiates
lipolysis of TG to produce DAG and FFA. PKA-activated HSL further hydrolyzes DAG
to MAG and FFA. MAG is finally hydrolyzed to glycerol and FFA by MGL. Glycerol
and FFA can be transported outside of the adipocyte by their respective transporter
proteins, while FFA can also diffuse through plasma membrane. Insulin binding to IR on
the surface of adipocyte activates PDE through PI3K/AKT pathway. PDE inhibits the
production of cAMP and consequently reduces the activity of PKA. On the other hand,
insulin promotes the translocation of GLUT4 to cell membrane and facilitates glucose
uptake into adipocyte which is converted to glycerol-3-phosphate (G3P) through
glycolysis. Insulin also activates LPL on adipocyte surface. Activated LPL releases FFA
from lipoprotein which is subsequently transported or diffuses into adipocyte.
Intracellularly, FFA is converted to acyl-CoA. G3P and acyl-CoA serves as substrates for
synthesis of TG at ER. PA, phosphatidic acid; LPA, lysophosphatidic acid.
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also exist in adult humans and are interspersed into the white adipose tissue (WAT)
(Giralt and Villarroya, 2013). But these brown adipocytes are different from the classical
brown adipocytes and share many similarities with the white adipocytes cell linage, and
therefore, sometimes are referred to as the “inducible, beige, brite” adipocytes (Giralt and
Villarroya, 2013). White adipocytes contain a single lipid droplet, while brown
adipocytes contain multilocular droplets and higher density of mitochondria. BAT can be
induced by cold or exercise (Cannon and Nedergaard, 2004), and primarily function to
promote non-shivering thermogenesis. Inducible thermogenic genes in BAT genes
include: uncoupling protein 1 (UCP1), PRD1-BF-1-RIZ1 homologous domain containing
protein-16 (PRDM16), peroxisome proliferator-activated receptor gamma (PPARȖ)
coactivator 1-alpha (PGC-1Į), PGC-1ȕ, and CIDEA (Kajimura et al., 2010).
WAT represents the majority of body fat. WAT can be further classified by its
location into subcutaneous adipose tissue which is underneath the skin and visceral (or
abdominal) adipose tissue which is located inside the abdominal cavity. Mesenteric,
epididymal white adipose tissue and perirenal depots all belong to visceral adipose tissue.
Although subcutaneous and visceral adipose tissues are both WAT, they are distinct in
terms of functional implications. For example, enlargement of visceral WAT is more
associated with metabolic syndrome than that of subcutaneous WAT (Ibrahim, 2010).
Visceral adipose tissue is also richer in blood and more innervated (Ibrahim, 2010). In
addition, visceral adipocytes are more metabolically active, hormonally responsive to
adrenergic-stimulated lipolysis than subcutaneous adipocytes (Arner, 1995; Arner et al.,
1990; Hellmer et al., 1992).
1.2.5 Hypertrophy and Hyperplasia of Adipose Tissue
Adipose tissue expands in obesity to store excess energy. As excess energy
accumulation within the body continues, adipocytes will expand in size (hypertrophy)
and/or increase in number (hyperplasia) to store more lipids. Hyperplastic growth is
found solely at early stages of adipose tissue development in human and the adipocyte
number become stable in adulthood (Spalding et al., 2008). In rodents, both size and
number of adipocyte can change along development of obesity, with the observation that
hypertrophy occurs prior to hyperplasia (Faust et al., 1978). Although it seems feasible to
combat obesity by restricting adipose tissue expansion, as hypertrophy and hyperplasia
are known to facilitate obesity, modulating transcription factors to inhibit adipocyte
development and adipose tissue expansion concomitantly affects metabolic homeostasis
(Stephens, 2012).
The dominant cell type within adipose tissue is mature adipocytes. Nonetheless,
endothelial cells, vascular smooth muscle cells, immune cells such as macrophages as
well as fibroblasts can also be found in the adipose tissue. In addition, adipocyte
precursor cells coexist within adipose tissue, which can be regenerated into mature
adipocytes through a process called adipogenesis.
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Several immortalized cellular models can be used to study adipogenesis, such as
the 3T3-L1 and 3T3-F442A cell lines derived from Swiss mouse embryos, embryonic
stem cells, primary mouse embryonic fibroblasts (MEFs), immortalized MEFs,
immortalized brown-adipose stromal cells, and immortalized multipotent precursor cells.
Nonetheless, the methodologies used to differentiate these cells may be different. The
3T3-L1 and 3T3-F442A cell lines could be differentiated to mature adipocytes when
treated with a hormonal cocktail, whereas the differentiation of immortalized MEFs
requires the overexpression of a pro-adipogenic transcription factor such as 33$5Ȗ or
CCAAT-enhancer- binding protein alpha (C/EBPĮ) (Rosen and MacDougald, 2006).
One of the major adipogenic regulators is the transcription factor 33$5Ȗ, which
is both necessary and sufficient for adipogenesis (Rosen et al., 2000). Other transcription
factors that facilitate adipogenesis include members of the C/EBP family, members of the
Krüppel-like factors (KLFs) family of proteins, STATs, and SREBP-1 (Sarjeant and
Stephens, 2012). However, 33$5ȖH[SUHVVLRQand/or activity are likely required for the
action of most of the pro-adipogenic factors (Rosen and MacDougald, 2006). Negative
transcription factors for adipogenesis include the surface protein preadipocyte factor1
(PREF1) and members of the GATA family, which function in part E\UHSUHVVLQJ33$5Ȗ
expression (Tong et al., 2000). These pro- and anti- adipogenic factors often work in
complex with co-activators or co-repressors. The most well-studied anti-adipogenic
nuclear receptor co-repressor is NcoR (Li et al., 2011). PPARȖ has two protein isoforms
that are generated by alternative splicing, i.e. PPARȖ1 and PPARȖ2. While these two
proteins are induced during adipogenesis, their relative importance remains elusive.
33$5ȖLV believed to be more efficient in promoting adipogenesis than the other
isoform PPARȖ1, but is not necessarily required for adipocyte development in vivo
(Mueller et al., 2002; Zhang et al., 2004).
1.3 NEDD4
1.3.1 E3 Ligases in Metabolism
The conjugation of ubiquitin to a protein substrate is a three-step process. In the
first step, the C-terminus of ubiquitin binds a Cys residue within a ubiquitin-activating
enzyme (E1) by forming a thioester bond. E1 enzyme activates the ubiquitin and transfers
it to a specific Cys residue within a ubiquitin-conjugating enzymes (E2s). E2s can then
transfer ubiquitin directly to substrates when working with RING (Really Interesting
New Gene) domain ubiquitin-protein ligases (E3s), or through specific HECT E3s. Nterminus of ubiquitin is thus linked to specific internal Lys residues of target proteins.
Substrates can undergo monoubiquitylation, multi-ubiquitylation or polyubiquitylation.
Polyubiquitylated proteins are normally degraded by the 26S proteasome (Rotin and
Kumar, 2009). Besides its most notable proteolytic function, ubiquitination also regulates
receptor internalization, protein lysosomal sorting, interaction, subcellular distribution,
and gene transcription, etc. (Chen and Sun, 2009).
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In recent years, several E3 ligases have been reported to be implicated in the
regulation of body metabolism. For example, the Casitas B-lineage lymphoma (Cbl)
homologue, Cbl-b, which belongs to the RING-type E3 ligase has been reported to
regulate obesity and macrophage activation. In a report by Hirasaka et al., Cbl-b-/- mice
displayed enhanced insulin resistance and macrophage activation in adipose tissue
(Hirasaka et al., 2007). A similar conclusion was reached in Abe et al.’s study: Cbl-b
deficiency enhanced saturated FFA-induced macrophage activation and exaggerated
HFD-associated insulin resistance (Abe et al., 2013). Depletion of another Cbl
homologue, c-Cbl, reduced adiposity, improved insulin sensitivity (Molero et al., 2004)
and protected mice against HFD-induced obesity (Molero et al., 2006). Other examples
are the muscle-specific mitsugumin 53 (MG53, also known as TRIM72) and cullin-7
(CUL7), two RING-type E3 ligases which mediated IRS-1 ubiquitination and
degradation, and therefore, negatively modulated insulin signaling (Lee et al., 2010; Xu
et al., 2008; Yi et al., 2013). Loss and overexpression of MG53, protected against and
triggered insulin resistance and metabolic syndrome in mice under HFD challenge (Song
et al., 2013). Depletion of ITCH, a HECT-type E3 ligase involved in T-cell
differentiation and inflammatory regulation, reversed HFD-induced obesity, the
associated insulin resistance and liver steatosis (Marino et al., 2014). The beneficial
effects of ITCH loss of function were likely due to the accelerated metabolism and
increased differentiation of M2 macrophages, as well as the enhanced fatty acid oxidation
in Itch-deficient mice (Marino et al., 2014). Consistently, in human adipose tissue,
expression of ITCH was negatively correlated with that of the M2 macrophage markers
(Marino et al., 2014).
1.3.2 NEDD4 and Its Substrates
Neural precursor cell expressed, developmentally down-regulated 4 (NEDD4) is a
HECT-type E3 ubiquitin ligase, which was first identified from a screen for
developmentally regulated gene in early embryonic mouse central nervous system (CNS)
in 1997 (Kumar et al., 1997). NEDD4 is believed to be the ancestral member of the 9membered NEDD4 family (Yang and Kumar, 2010). Mouse and rat NEDD4 are almost
identical with only two amino acids difference. However, human NEDD4 has 5 splice
variants ranging from 900 to 1302 amino acid in length. NEDD4 contains an N-terminal
C2 domain for calcium/lipid and/or protein binding, 3 to 4 WW domains for protein–
protein interaction, and a C-terminal catalytic ligase domain (HECT domain). WW
domains is the main component determining the substrates binding by NEDD4 via
binding PPxY (PY) or LPSY motifs, although the C2 domain of NEDD4 also bind
substrates (Yang and Kumar, 2010).
Despite the fact that many studies support NEDD4 as a critical player in early
embryonic development (Cao et al., 2008; Fouladkou et al., 2010; Liu et al., 2009),
knowledge toward the patho-physiological functions of this protein in postnatal life is
limited. Recent experimental results indicate that NEDD4 plays a pivotal role in
regulating receptor signaling by regulating receptor endocytosis (Rotin et al., 2000), A
partial list of substrates of NEDD4 includes: epidermal growth factor receptor (EGFR)
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(Lin et al., 2010), vascular endothelial growth factor receptor 2 (VEGF-R2) (Murdaca et
al., 2004), insulin-like growth factor receptor type 1 (IGF-1R) (Vecchione et al., 2003),
IR (Ramos et al., 2006), Notch1 (Koncarevic et al., 2007), PTEN (Wang et al., 2007),
beta-2 adrenergic receptor (ȕ2-AR) (Nabhan et al., 2010; Shenoy et al., 2008), fibroblast
growth factor receptor (FGFR1) (Persaud et al., 2011), AKT (Fan et al., 2013), and Ras
(Zeng et al., 2014). Since most of these substrates of NEDD4 are active players in various
metabolic pathways, hence, we hypothesized that NEDD4 could be a new player in the
regulation of metabolism.
1.3.2.1 IGR-1R and IR. In several cell-based studies, NEDD4 was found in
complex with growth factor bound-receptor 10 (Grb10) to mediate ligand-stimulated IR
and IGF-1R ubiquitination, which subsequently facilitated their internalization and/or
degradation (Monami et al., 2008; Ramos et al., 2006; Vecchione et al., 2003). Reduction
in NEDD4 expression was presumed to stabilize IR and IGF-1R upon ligand stimulation,
and thus potentiats insulin and IGF-1 signaling. However, more recent evidence from in
vivo studies revealed that insulin/IGF-1 signaling in NEDD4 knockout embryos were
reduced, suggesting a more complex role of NEDD4 in vivo. Mice homozygous for
targeted mutation of the Nedd4 gene died during or shortly after birth and exhibited
severe intrauterine growth retardation (body weight of Nedd4-/- embryos and newborn
pups were only 35% of normal) (Cao et al., 2008; Liu et al., 2009). The growth
deficiency in Nedd4-haploinsufficient mice are similar in severity to the previously
characterized mice carrying an Igf1r null mutation (45% of normal birth weight) (Baker
et al., 1993; Liu et al., 1993), suggesting an impaired IGF-1 signaling in the absence of
NEDD4 during embryogenesis. Indeed, in cultured Nedd4-/- MEFs, cell surface
expression of both IGF-IR and IR were found to be substantially reduced (Cao et al.,
2008). Additionally, the authors speculated that reduction in insulin and IGF-1 signaling
by NEDD4 depletion is likely through increased expression of Grb10 (Cao et al., 2008), a
known negative regulator for IR and IGF-1R function. The level of Grb10 was elevated
in NEDD4 knockout MEFs, which may in turn impede insulin/IGF-1 signaling. The
lethality of NEDD4 knockout mice could be partially rescued by crossbreeding with
Grb10-deficient mice (Cao et al., 2008). Since Grb10 also binds IR (Liu and Roth, 1995)
which shares structural and downstream signaling similarities with IGF-1R, it is possible
that NEDD4 also regulates insulin signaling via elevated Grb10; Grb10 associates
preferentially with IR as compared with IGF-1R (Laviola et al., 1997).
1.3.2.2 ȕ2-AR. Agonist treatment for different length of time resulted in different
effects on ȕ2-AR trafficking. Short exposure within 1 hr caused internalization of the
phosphorylated receptor which were recycled to the membrane after dephosphorylation;
prolonged exposure from hours to days caused receptor protein degradation (Shenoy et
al., 2001). NEDD4 has been demonstrated to be an essential E3 ligase mediating agoniststimulated ubiquitination and degradation of ȕ2-AR (Nabhan et al., 2010; Shenoy et al.,
2008). In Shenoy et al.’s study, expression of a dominant negative NEDD4 or siRNA
targeting NEDD4 specifically inhibited isoproterenol-induced ubiquitination and
degradation of the ȕ2-AR in HEK-293 cells, whereas other closely related E3 ligases had
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no effects (Shenoy et al., 2008). Moreover, the interaction between NEDD4 and ȕ2-AR
was ablated by an siRNA targeting arrestin beta 2 (ȕ-arrestin2), suggesting an adaptor
role for ȕ-arrestin2 in the interaction (Shenoy et al., 2008). In Nabhans et al.’s study, an
alpha arrestin, arrestin domain-containing 3 (ARRDC3), was found to be involved in ȕ2AR downregulation as revealed by a genome-wide RNA interference screen using a cell
line that expressed DGLVWDOO\WUXQFDWHGIRUPRIȕ2-AR (ȕ2-ARt) (Nabhan et al., 2010), as
the ȕ2-ARt underwent faster receptor degradation upon agonist stimulation than the wildtype receptor (Cao et al., 1999). Interestingly, they found that ARRDC3 also served as an
adaptor protein that regulated ȕ2-AR via recruiting the E3 ligase NEDD4 (Nabhan et al.,
2010) (Figure 1.2). In support of these in vitro observations, in vivo evidence collected
by another group of researchers showed that the Arrdc3-deficient mice were resistant to
age-induced obesity (Patwari et al., 2011). The Arrdc3-deficient mice exhibited enhanced
energy expenditure with increased thermogenesis in both BAT and WAT, and enhanced
cAMP accumulation and lipolysis in response to norepinephrine (Patwari et al., 2011),
suggesting increased ȕ-AR signaling in vivo when the interaction between NEDD4 and
ȕ2-AR was abrogated.
1.4 Summary
The HECT-type E3 ubiquitin ligase NEDD4 has a large number of substrates that
are active players in the growth factor receptor signaling, implying a potential role of
NEDD4 itself in regulating whole-body metabolism. Besides the receptors mentioned
previously, PTEN (Kwak et al., 2010; Wang et al., 2007), AKT (Fan et al., 2013), and
Ras (Zeng et al., 2014) are also demonstrated to be the substrates of NEDD4 in different
context. To investigate the function of NEDD4 in metabolic regulation in vivo, we
characterized the metabolic phenotypes of Nedd4-haploinsufficient mice in a dietinduced obesity (DIO) model, due to the fact that homozygous Nedd4 deletion causes
embryonic/perinatal lethality. In this study, we also tested the possible impact of NEDD4
reduction on cognitive function and anxiety behaviors, as NEDD4 is highly expressed in
the brain and regulates several growth factor receptor signaling pathways involved in
CNS development and function.
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Figure 1.2 5HJXODWLRQRIȕ2-AR Endocytosis and Degradation by NEDD4.
Ligand binding induces phosphorylation within ȕ2-AR and the recruitment of Į- or ȕarrestins to the receptor. The Į- or ȕ-arrestins serve as the binding sites for the WW
domains of NEDD4, therefore bringing NEDD4 in proximity to ȕ2-AR. The HECT
domain within NEDD4 catalyzes ubiquitination of ȕ2-AR serving as a signal for receptor
endocytosis and subsequent degradation.
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CHAPTER 2.

MATERIALS AND METHODS
2.1 Animal Studies

The Nedd4-haploinsufficient mice (Nedd4Gt(OST16211)Lex) were originally generated
by Lexicon Genetic Incorporated and are stocked at the Mutant Mouse Regional
Resource Center (MMRRC) (http://www.mmrrc.org/strains/11742/011742.html). All
mice were kept on a 12/12 light/dark cycle with lights on at 6:00 AM in a pathogen-free
animal facility. The animals had ad libitum access to water and food at all times. Food
was only removed when required.
2.1.1 Genotyping
Tail tissue (2-5 mm) from young (< 21 days) mice was taken by a sterilized
scissor. DNA was isolated by phenol-chloroform extraction. PCR was performed with
GoTaq Flexi DNA Polymerase (Promega). Nedd4 mice were genotyped by PCR with the
following primer sequences: Nedd4 wild type allele-forward GGA GTC TTT GGA TAT
TGT AAG AGC; Nedd4 mutant allele-forward AAA TGG CGT TAC TTA AGC TG
CTT GC; and a common reverse GAG CGT GCG CCT CAC AAG TAT GA.
2.1.2 Food Intake, Body Weight, and Body Length Measurement
Mice were fed either a normal control diet (8640, Teklad, Harlan Laboratories)
with 17% of total calories from fat, 54% from carbohydrate and 29% from protein, or a
HFD (TD.06414, Teklad, Harlan Laboratories) with 60.3% of total calories from fat,
21.3% from carbohydrate and 18.4% from protein, starting from 6 weeks of age. The
HFD is packed in the form of pellet and kept at 4°C until use. For food intake
measurement, mice at 12-16 weeks of age were ad-libitum fed a known amount of food.
After 24 hr, the remaining food pellets were weighed. The consumption of food (absolute
food intake) was calculated by the difference. Animals’ food intake was monitored on a
daily basis for a continuous 7-day period. Body weights were monitored on a weekly
basis with a small scale. For body length measurement, mice between 12-16 weeks of age
were anesthetized or euthanized. Then a ruler was hold up against the body to measure
the length from nose to anus.
2.1.3 Glucose Tolerance Test (GTT) and Insulin Tolerance Test (ITT)
For GTT, mice fasted overnight were weighed. Glucose were intraperitoneally
(i.p.) injected to the mice at a dose of 1.5 g/kg body weight. Blood glucose level was
measured with a glucometer (OneTouch Ultra glucometer, LifeScan) in a drop of blood at
time 0 (before the injection of glucose) and 30, 60, 90, 120, and 180 min after glucose
injection. For ITT, mice were fasted for 4 hr and then i.p. injected with insulin at 0.75
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U/kg body weight. Blood glucose concentrations were read from a glucometer with a
drop of blood at time 0 and 30, 60, and 90 min after insulin administration.
2.1.4 Insulin Signaling
For peripheral insulin signaling analysis, adult mice fasted overnight were i.p.
injected with 5 U/kg of insulin diluted in normal saline or an equal volume of saline.
Mice were euthanized 15 min after injection. Liver, gastrocnemius muscle, and
epididymal WAT were dissected and immediately frozen in liquid nitrogen. For central
insulin signaling analysis, P0 neonatal mice were euthanized by decapitation. The entire
brains were carefully removed by opening the skull with a dissecting scissor. The isolated
brains were placed in a clean tissue culture plate (100 mm) containing sterile Hank's
Balanced Salt Solution (HBSS). Under a light microscope, the cerebellum was removed;
then the thin and transparent layer which contains fibrous and vascular tissues
surrounding the forebrain was gently removed by dissecting forceps. Tissues containing
hypothalamus, amygdala, thalamus and striatum were carefully removed by dissecting
forceps. Other non-cortical tissues were also carefully removed, leaving only a thin layer
of cortical tissue. These cortical tissues were minced into pieces of relatively equal size
with dissecting forceps and placed into different wells prefilled with 500 ȝl of HBSS of a
24-well plate. These tissues were then incubated with insulin at different doses or for
different time (up to 60 min). Tissue lysates were subjected to Western-blot analysis.
2.1.5 Measurement of Metabolites and Hormones
Blood was collected through lateral saphenous vein. Briefly, the animal was
secured in a restrainer. The rear leg was stretched out to its natural position. The hair was
removed by a small shaver and swabbed using 70% ethanol. The vessel was punctured
with a 25-26 gauge needle and blood was collected with a heparinized capillary tube.
Blood glucose levels were measured using a glucometer as mentioned in GTT and ITT.
After collection of blood, the blood was allowed to clot by leaving it undisturbed at room
temperature (RT) for 30 min. Serum was obtained by centrifuging clotted blood in tubes
at 1,600 g for 10 min at 4°C and stored at -80°C until use. Serum insulin levels were
determined with murine ELISA kits (Crystal Chem). Total serum TGs, glycerol,
cholesterol, and FFAs were assayed using enzymatic methods with a colorimetric or
fluorometric assay kit (Cayman). Serum insulin levels during GTT were determined with
a murine ELISA kits (Crystal Chem).
2.1.6 Histology
Mouse was cardiac-perfused first with phosphate buffered saline (PBS) to clear
blood, then with 4% paraformaldehyde (PFA) for fixation. Epididymal adipose tissue and
liver was dissected and post-fixed in 4% PFA for 24 hr. Adipose tissue was subjected to
paraffin embedding and sectioning to 10 ȝPVOLFHVLiver was immersed in 30% sucrose
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prepared in PBS for dehydration, then embedded in optimum cutting temperature
compound (OCT), and cryosectioned with a cryostat (Leica CM 1860).
Hematoxylin and eosin (H&E) staining of sections was performed according to
standard procedures (Fischer et al., 2008). Briefly, sections were stained with
hematoxylin for nuclei, rinsed with running tap water, counterstained with eosin, and
dehydrated before mounting. The paraffin embedded sections were dewaxed and
rehydrated by sequentially immersing in xylene, ethanol, and water before H&E staining.
Microscopic pictures were taken and adipocyte size was measured in 300-400 cells per
mouse in randomly selected fields using ImageJ software (National Institutes of Health,
Bethesda, Maryland; http://imagej.nih.gov/ij/). For Oil red O staining in liver,
cryosections were air dried and fixed in 10% formalin. Sections were briefly washed with
running tap water, immersed in 60% isopropanol for 5 min, and stained with freshly
prepared oil red O working solution for 15 min. Then, sections were briefly
counterstained for nuclei with hematoxylin, rinsed with distilled water and mounted with
glycerine jelly.
2.1.7 Lipolysis Assay
During the in vivo lipolysis assay, the non-selective ȕ-agonist isoproterenol was
i.p. injected into mice fasted overnight, at 10 mg/kg body weight. Blood samples were
collected at time 0 and 10, 30, and 60 min after the injection. The ex vivo lipolysis assay
was performed as described in (Qiao et al., 2011). During primary adipocyte lipolysis
assay (Viswanadha and Londos, 2006, 2008), minced epididymal WAT was digested in a
Krebs-Ringer bicarbonate (KRB) buffer (pH 7.4) plus 3% fatty acid-free BSA fraction V,
0.5 mM adenosine, and 1 mg/mL type I collagenase at 37°C for 45 min. After digestion
and three washes with KRB plus 3% fatty acid-free BSA, the dissociated adipocytes were
counted with a hemocytometer under a microscope. Approximately 12,000 adipocytes
were resuspended in 400 ȝL KRB buffer plus 3% fatty acid-free BSA. Isoproterenol was
then added to the buffer DWȝ0$IWHU hr incubation at 37°C with gentle shaking,
samples were centrifuged and the infranatant (media below the floating adipocyte layers)
was removed and stored at -80°C before use. Glycerol levels were measured by using a
colorimetric assay kit (Cayman) following the manual.
2.1.8 Fear Conditioning
Mouse was subjected to fear conditioning training on day 1, a context fear
retrieval test and a tone fear retrieval test (at least 3 hr apart) on day 2. In the fear
conditioning trial, mouse was gently placed in a chamber of 30 × 30 × 25 cm in
dimension (Coulbourn Instruments). After a 3 min recording for baseline activity, two
paired tone-shock stimuli were presented one minute apart. The paired tone-shock stimuli
consisted of a 20 sec tone (2800 Hz, 82 dB) and a 2 sec electrical footshock (0.7 mA) at
the distal end of the tone. One minute after the second tone-shock stimulus, mouse was
returned to its home cage. During the context fear retrieval trial on day 2, mouse was
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placed back to the same chamber for a 3 min period. The freezing time of the mouse
during the testing period was recorded. During the tone fear retrieval trial on day 2,
mouse was placed in the same box decorated with colored plastic boards. After a 3 min
recording for baseline activity, a 20 sec tone similar to day 1 was presented. The freezing
time of the mouse during the testing period was recorded. All experiments were
conducted between 9 AM and 5 PM.
2.1.9 Cross Maze
Mouse was placed in the entry arm of the cross-maze and allowed to explore
freely for 5 min with a camera on top. At the end of the study, videos were replayed. The
pattern of arm choices was recorded and the total number of entries was counted. An
entry was counted when four limbs of the mouse are in the arm.
2.1.10 Morris Water Maze Test
At approximately 2 months of age, the spatial learning and memory in the young
Nedd4 mice and their littermates were evaluated by the Morris water maze test (Morris,
1984). During the water maze test, mouse was allowed to swim in a circular pool (114 cm
in diameter). Water was colored with a non-toxic paint to make opaque. A circular escape
platform of 10 cm in diameter was placed under the surface of the water about 0.5 cm in
depth, to allow the mouse to escape from swimming. Four trials per day were conducted
during the visible and hidden platform training. In the visible platform training, the
submerged escape platform was marked by a visible sign above the surface of the water.
Mouse was released into the swimming pool at different positions during each of the four
trials. The latency for the mouse to find the platform was recorded. Mouse that did not
find the platform in 60 sec was assisted to stay on the platform for an additional 10 sec.
After the training section, mouse was tested a probe trial, in which the platform was
removed from the pool and mouse was allowed to swim for 60 sec. The swimming track
of mouse was recorded.
+/-

2.1.11 Open Field Test
Mouse was placed in an open-field box (47 × 37 × 20 cm, Accuscan Instruments),
equipped with 16 infrared beams that automatically measures total locomotor activity by
beam-breaks and with a camera on top that measures the distance the mouse travelled.
Mouse was gently placed in the box and allowed to explore freely for 10 min. About 25%
of the field (47 × 37 × 20 cm) was determined as center. Experiments were performed
between 9 AM to 5 PM.
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2.1.12 Light/Dark Exploration
A plastic chamber (27 × 27 cm in dimension) was used for light/dark exploration.
The chamber was segregated into opaque and non-opaque compartments. Mouse was
allowed to transit between the two compartments through a hole on the segregation wall.
Mouse was placed in the light side and allowed to explore for a 5-min session. The
movement of mouse was recorded by a camera on top. Several parameters (latency to
enter the dark, latency to re-enter the light, total time spent in the dark compartment and
the number of transitions between lighted and dark compartments) were analyzed at the
end of the study.
2.2 Biochemical Studies
2.2.1 Cells
The 3T3-L1 preadipocytes were cultured in Dulbecco's Modified Eagle Medium
(DMEM) supplemented with 10% bovine calf serum. Cells were split 1:10 every 2 days
to prevent reaching confluency. For adipocyte differentiation, the preadipocytes were
allowed to grow to confluency in 10% bovine calf serum. Two days post confluency,
cells were switched to DMEM supplemented with 10% fetal bovine serum (FBS) and
stimulated with a differentiation cocktail (IDX) containing 0.5 mM
isobutylmethylxanthine (IBMX), 1 ȝM dexamethasone, and 1.5 ȝg/mL insulin. Three
days after IDX induction, cells were fed with DMEM plus 10% FBS and 1.5 ȝg/mL
insulin. Three days after, cells were cultured in DMEM plus 10% FBS and media was
replaced every 2-3 days until full differentiation was achieved. The HEK293 cells were
cultured in DMEM supplemented with 10% FBS. The HEK293 cells stably expressed
FLAG-tagged ȕ2-AR (a kind gift from Dr. Suleiman Bahouth at UTHSC) were
maintained in DMEM plus 10% FBS and 200 ȝg/mL of G418. Media was replaced every
2-3 days. All cells were incubated in 95% O2 and 5% CO2 at 37°C.
2.2.2 Adeno-associated Virus (AAV)-mediated Knockdown
AAV-mediated knockdown of NEDD4 was performed by using the
pAAV2.1.CMV.EGFP-U6.shRNA plasmid vector (a kind gift from Dr. Tonia Rex at
Vanderbilt University) expressing short hairpin RNA (shRNA) targeting NEDD4 mRNA.
Of three different shRNA constructs tested, the one showing most effective
downregultion of NEDD4 protein and Nedd4 mRNA (50%) was chosen for subsequent
studies. The targeting sequence is TGG CGA TTT GTG AAC CGT A. Virus production
was performed by the Gene Transfer Vector Core at the University of Iowa.
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2.2.3 Western-blot Analysis
Cells or tissues were lysed with radioimmunoprecipitation (RIPA) buffer
supplemented with protease and phosphatase inhibitors. Cell debris in lysates was
removed by centrifugation at maximum speed at 4°C. Protein concentrations were
determined by the bicinchoninic acid (BCA) method (Pierce). Five to 40 ȝg of protein of
each sample was electrophoresed on a Novex 4–20% Tris-Glycine gel (Invitrogen). After
transferring the proteins to PVDF membrane, the membrane was blocked at RT in 1 ×
Tris Buffered Saline plus 0.05% Tween-20 (TBST) containing 5% non-fat dry milk for 1
hr. After blocking, membrane was incubated overnight at 4°C in primary antibody diluted
in TBST/5% BSA/0.02% NaN3. On the second day, the membrane was washed
thoroughly with TBST and incubated in secondary horseradish peroxidase (HRP) linked
antibody (GE Healthcare Life Sciences). Blot was washed three times with TBST
followed by incubation with enhanced chemiluminescence (ECL) for signal development.
2.2.4 Co-immunoprecipitation (Co-IP)
Cells were lysed in a co-IP buffer (25 mM Tris-HCl, 150 mM NaCl, and 1% NP40) supplemented with protease and phosphatase inhibitors. After determining protein
concentrations, 300-1,000 ȝg of total protein was resuspended in co-IP buffer. Then, 1-3
μg of antibody and 30 μl of protein A/G beads (Santa Cruz) were added to each sample
for overnight incubation with gentle shaking at 4°C. On the second day, beads were
centrifuged at 8,000 rpm for 2 min, washed three times with the co-IP buffer, and finally
resuspended in 1 × SDS sample buffer and denatured in boiling water for 5 min. Samples
were centrifuged again at maximum speed and the resulting supernatant was loaded
directly on a Tris-Glycine gel or stored at -80°C until use.
2.2.5 RNA Isolation, cDNA Synthesis, and qRT-PCR
Total RNA was isolated using Trizol reagent (Invitrogen). For the 3T3-L1
adipocyte samples, 500 ȝl Trizol reagent was applied per well in a 12-well plate; for
adipose tissue samples, 1 ml Trizol reagent was applied per 50-100 mg of tissue. Cells
were lysed by scraping or using a homogenizer. A proportional volume of chloroform
was added to the samples (0.2 ml per 1 ml of Trizol reagent used) and mixed thoroughly
by shaking for 15 sec. The homogenates were allowed to sit at RT for 2-3 min, and
subjected to centrifugation at 12,000 × g for 15 min. The following steps were performed
as described previously (Li et al., 2014). Primers used are listed in Table 2.1.
2.2.6 Crude Membrane Fraction
For crude membrane fraction from primary adipocytes, epididymal WAT was
minced and digested in KRB buffer (pH 7.4) supplemented with 3% fatty acid-free BSA
fraction V, 0.5 mM adenosine, and 1 mg/mL type I collagenase at 37°C for 45 min. After
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Table 2.1 Primers Used for qRT-PCR.
Name
Leptin
MIP-Į
MCP-1
F4/80
71)Į
,/ȕ
IL4
IL10
UCP1
UCP2
UCP3
PGC-Į
PGC-ȕ
CIDEA
PRDM16
NEDD4
aP2
&(%3Į
33$5Ȗ

Forward Primer Sequences
caggatcaatgacatttcacaca
atgaaggtctccaccactgc
catccacgtgttggctca
cctggacgaatcctgtgaa
ccctcacactcagatcatcttct
agcttcaggcaggcagtatc
ggtctcaacccccagctagt
ctggacaacatactgctaaccg
ggcctctacgactcagtcca
tttgggtttggttgtttttga
tacccaaccttggctagacg
gaaagggccaaacagagaga
ctccagttccggctcctc
ttcaaggccgtgttaagga
cctaaggtgtgcccagca
acgtgctgttcactgctgat
ggatggaaagtcgaccacaa
gagcaaaaatgtgccttgatatt
gaaagacaacggacaaatcacc
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Reverse Primer Sequences
gctggtgaggacctgttgat
cccaggtctctttggagtca
gatcatcttgctggtgaatgagt
tcccagagtgttgatgcaaa
gctacgacgtgggctacag
gtcacagaggatgggctctt
gccgatgatctctctcaagtgat
gggcatcacttctaccaggtaa
taagccggctgagatcttgt
ggaggcagatgcaggtagat
gtccgaggagagagcttgc
gtaaatcacacggcgctctt
ccctctgctctcacgtctg
cctttggtgctaggcttgg
caccttccgcttttctaccc
tcacaactcgtgtgtcatcg
tggaagtcacgcctttcata
tgcacccttcatttttctcac
gggggtgatatgtttgaacttg

digestion and three washes with KRB plus 3% fatty acid-free BSA, the dissociated
adipocytes were resuspended in one volume of STE buffer (10 mM Tris-HCl pH 7.5, 1
mM EDTA pH 8.0, 250 mM sucrose) prewarmed to 37°C supplemented with protease
and phosphatase inhibitors. The adipocytes were homogenized at RT by six strokes of a
large-bore Potter-Elvehjem homogenizer (Arthur H. Thomas Co.) fitted with a serratededge Teflon pestle. The homogenizer was driven by an Eberbach Con-torque motor
operating at maximum speed. The homogenate was then transferred to a round bottom
tube and spun at 50,000 × g for 30 min at 4°C. The pellet which contains the crude fat
cell membrane was resuspended in 10 volumes of 50 mM Tris-HCl, 10 mM MgCl2, pH
8.0 containing protease and phosphatase inhibitors at 4°C and homogenized for 10strokes as mentioned above. The homogenate was spun at 15,000 × g for 15 min at 4°C.
The pellet was resuspended in RIPA buffer on ice for at least 1 hr. The lysate was spun
again at maximum speed. The supernatant which contains the membrane proteins was
transferred to a new tube for subsequent analysis.
For crude membrane fraction from HEK293 cells, cells were homogenated in one
volume of STE buffer plus protein and phosphatase inhibitors by passing through a 25
gauge needle. The homogenates were transferred to a round bottom tubes and spun at
50,000 × g for 30 min at 4°C. The pellet was washed once in STE buffer containing
protease and phosphatase inhibitors and spun again at 50,000 × g for 30 min at 4°C. The
pellet was dissolved in RIPA buffer on ice for at least 1 hr. The lysate was spun again at
maximum speed. The supernatant which contains the membrane proteins was transferred
to a new tube for subsequent analysis.
2.2.7 Oil Red O Staining in Differentiated 3T3-L1 Cells
A stock Oil Red O solution was prepared by weighing out 150 mg of Oil Red O
powder and adding this to 50 mL of isopropanol. Then, 3 parts of Oil Red O stock
solution with 2 parts distilled water were mixed and incubated for 10 min at RT. The Oil
Red O working solution was filtered through Whatman filter paper. For Oil red O
staining of differentiated 3T3-L1 adipocytes, cells cultured in a 35 mm dish were first
fixed in 10% formalin for 30-60 min. Cells were then briefly rinsed with 3 times with
distilled water and incubated with 60% isopropanol for 5 min. Freshly prepared Oil red O
working solution were added to the cells for 5 min. Cultures were rinsed with RT tap
water until the water rinses were clear.
2.2.8 Dual Luciferase Reporter Assay
HEK293 cells of relatively equal numbers were plated on 24-well plates. On the
second day, seeded cells were transiently cotransfected with 250 ng 3 hPPRE-Luc, 250
ng 33$5Ȗ2-Flag, 10 ng Renilla luciferase control reporter vector pRL-SV40 and 250 ng
of other plasmids using Lipofectamine 2000 transfection reagent (Invitrogen). At 32 hr
after the transfection, cells were WUHDWHGZLWKRUZLWKRXW5RVLJOLWD]RQH ȝ0 IRUKU
At 48 hr after the transfection, luciferase assay was performed by a dual luciferase assay
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system (Promega) according to the manufacturer’s instructions. The luciferase activity
was adjusted by the Renilla luciferase activity to remove the variation caused by
transfection efficiency. As NEDD4 overexpression or knockdown did not affect the
survival of HEK293 cells, we did not normalize the luciferase activity to protein content.
2.3 Materials
2.3.1 Antibodies
Anti-NEDD4 was purchased from Millipore; anti-ȕ1-AR (V-19), anti-ȕ2-AR (H20), anti-CEBP/Į (D-5), and anti-PPARȖ (E8) mouse monoclonal antibodies were
purchased from Santa Cruz; another anti-PPARȖ rabbit polyclonal antibody was from
Thermo Scientific; anti-phospho-IGF-15ȕ 7\U IRȕ 7\U  + 
anti-,5ȕ, anti-IGF-1Rȕ, anti-AKT, anti-AKT (Thr308), anti-AKT (Ser473), anti-STAT3,
anti-STAT3 (Tyr705), anti-mTOR, anti-mTOR (Ser2448), anti-AMPK, and anti-AMPK
(Thr172) antibodies were from Cell Signaling Technology.
2.3.2 Reagents
Hematoxylin, eosin, Oil Red O, insulin from bovine pancreas, (-)-isoproterenol
hydrochloride, rosiglitazone, IBMX, dexamethasone, MG-132, cycloheximide (CHX),
and chloroquine were purchased from Sigma-Aldrich; recombinant mouse leptin from E.
Coli was from ProSpec; ICI 118,551 hydrochloride, CGP-20712 dihydrochloride,
xamoterol hemifumarate, and salmeterol xinafoate were from Toris Bioscience.
2.3.3 Plasmids
The pcDNA3-PPARȖ2-Flag was obtained from Addgene; pRc-CMV-T7-NEDD41-WT and pRc-CMV-T7-NEDD4-1-CS were kind gifts from Dr. Daniela Rotin at The
Hospital for Sick Children in Canada; pSUPER-shNEDD4 was generated by our
laboratory (Kwak et al., 2010); PPRE h 3-TK-luc plasmid containing three copies of the
PPAR response element (PPRE) upstream of a luciferase reporter was a generously
provided by Dr. Edwards Park at UTHSC.
2.4 Statistics
Data were analyzed by GraphPad Prism 5.0. Two-tailed Student's t-test was used
for statistical comparison between two groups; two-way ANOVA followed by bonferroni
post-test correction was used for statistical comparison between groups when there were
two factors.
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CHAPTER 3.

METABOLIC PHENOTYPE STUDIES
3.1 Introduction

Obesity results from loss of homeostasis between lipid, protein, and carbohydrate
metabolism. The delicate balance between protein synthesis and protein breakdown is
crucial to keep our internal homeostasis under tight control. Protein degradation, or
proteolysis is one of the strategies employed by the cell to remove abnormal proteins and
prevent their aggregation, or to irreversibly inactivate proteins that are no longer needed
(Ciechanover, 2005). The amino acids generated by protein degradation may then be
reused for protein synthesis.
Besides the cell’s autophagy-lysosome proteolysis, the ubiquitin-proteasome
proteolysis represents a major protein degradation pathway. Defects in ubiquitindependent proteolysis have been associated with a number of human diseases, including
metabolic disorders (Sakamoto, 2002). Although there are very few studies published so
far, the importance of ubiquitin-dependent proteolysis in metabolic regulation is
increasingly emphasized. The ubiquitin-proteasome system (UPS) requires the sequential
and cooperative actions of E1, E2, and E3 enzymes. While E1 and E2 enzymes process
ubiquitin, the E3 ligases are the main enzymes responsible for substrate specificity
(Scheffner et al., 1995). Several members of the E3 ubiquitin ligase family have emerged
as regulators of metabolism, as evident in the knockout mice for mitsugumin 53 (Song et
al., 2013), ITCH (Marino et al., 2014), and two members of the Casitas B-lineage
lymphoma (Cbl) family—Cbl-b and c-Cbl (Abe et al., 2013; Hirasaka et al., 2007;
Molero et al., 2004; Molero et al., 2006). The involvement of these E3 ligases in HFDIO
suggests important roles for E3 ligases in metabolic regulation.
Rsp5p, the most well-studied yeast E3 ligase, participates in important cellular
processes including lipid and membrane synthesis (Hoppe et al., 2000). Its mammalian
homologues —NEDD4 and ITCH —are two structurally related E3 ligases belonging to
the nine-member HECT NEDD4 family. NEDD4 and ITCH both recognize proline-rich
consensus sequence motifs (e.g., PPxY and PPLP), and thereby ubiquitinate several
overlapping targets in vitro (Bray, 2006), including the aforementioned Cbl proteins
(Magnifico et al., 2003). Comparison study of immunity using genetically modified mice
indicates that they regulate distinct pathways in vivo (Yang et al., 2008). Comparing and
distinguishing NEDD4 and ITCH regulated pathways in vivo are of particular importance
to validate them as therapeutic targets. Recently, depletion of ITCH in mice was found to
reverse HFD-induced obesity and its related metabolic disorders (Marino et al., 2014).
Since NEDD4 knockout mice are embryonic/perinatal lethal, we created a HFDIO model
in Nedd4-haploinsufficient mice.
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3.2 Results
3.2.1 Genotype Verification of Nedd4-haploinsufficient Mice
The Nedd4-haploinsufficient (Nedd4+/-) mice we used in this study were originally
generated by Lexicon Genetic Incorporated. A gene-trapping vector insertion strategy
was employed to disrupt the third WW domain between exon 17 and exon 18 (Figure
3.1A). The gene trap targeted Nedd4+/- mice were generated on a 129/SvEvBrd h
C57BL6/J mix genetic background. A breeding pair (a male Nedd4+/- and a female wild
type) together with a female Nedd4+/- were transferred from Dr. Weichun Lin’s
laboratory (University of Texas Southwestern Medical Center). The Nedd4+/- mice were
viable, fertile, and devoid of gross phenotypic defects. However, a null mutation of
Nedd4 (Nedd4-/-) in mice leads to embryonic or perinatal lethality: most of the Nedd4-/mice died between E15.5-E18.5 before birth with few Nedd4-/- mice born and died on P0
(Liu et al., 2009). Based on my observation, most of the Nedd4+/- mice could live for at
least 18 months.
We performed polymerase chain reaction (PCR) genotyping for Nedd4+/- mice
and western blot analysis for Nedd4+/- and Nedd4-/- P0 neonatal mice, confirming the
presence of gene trap vector in Nedd4+/- mice; reduction and absence of NEDD4 protein
in Nedd4+/- and Nedd4-/- P0 neonatal mice, respectively (Figure 3.1B and C). To
characterize the extent of NEDD4 protein reduction in Nedd4+/- mice in different organs,
two pairs of Nedd4+/- mice and their wild-type littermates were euthanized. As expected,
NEDD4 protein levels were reduced at least 50% in all organs tested (Figure 3.1D).
3.2.2 Nedd4-haploinsufficient Mice Resist HFD-induced Obesity
To elucidate the physiological role of NEDD4 and to examine the phenotype of
Nedd4+/- mice, we placed a cohort of 6-week old Nedd4+/- and wild-type mice on either a
ND (17% calories from fat) or a HFD (60% calories from fat), and monitored their body
weights until age 9 months. When fed a ND, Nedd4+/- mice were lighter than their wildtype control mice from 6 weeks of age to until at least 9 months old in both genders (3.66
± 0.05g in male, 1.90 ± 0.03g in female) (Figure 3.2A). Their weight gain from 6 weeks
to 9 months old were comparable between Nedd4+/- and wild-type mice (Figure 3.2B),
suggesting that they grow in similar speed. The Nedd4+/- mice had reduced body mass at
birth, and this difference in body mass was carried over into adulthood.
Surprisingly, in response to a HFD, there was a profound difference in the
increase of body weight between Nedd4+/- and wild-type mice in both males and females
(Figure 3.2A). After 30 weeks of HFD feeding, the total body weight gain in Nedd4+/mice decreased around 30% (P<0.001). At the end of the feeding, mice on ND had
roughly 15 g increase in body mass in both Nedd4+/- and wild-type mice; the wild- type
mice on HFD had an average of 43.2 ± 1.0 g increase in body weight, while there was
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Figure 3.1 PCR and Western-blot Confirmation of Genotypes.
(A) A gene-trapping vector was inserted to the third WW domain of Nedd4 gene,
disrupting between exon 17 and exon 18. (B) Representative image of PCR genotyping of
wild-type (WT) and Nedd4+/- (Het) mice. Amplified DNA fragments were visualized on
an agarose gel stained with ethidium bromide. The 137-bp amplicon represented the
mutant allele. (C) Analysis of whole-body tissue lysates from P0 neonatal mice by
Western blot using an antibody against NEDD4. (D) Western blot analysis was
performed in protein lysates from various organs, from two 2-month-old males.
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Figure 3.2 Nedd4-haploinsufficient Mice on HFD Exhibit Less Weight Gain.
(A) Body weight curves of littermate mice fed a normal diet (ND) or a high-fat diet
(HFD) in males and females (n=8-11 per group). Mice at 6-week of age were started to
be fed a HFD for 30 weeks. Body weights were monitored on a weekly basis. (B)
Average weight gain after 30 weeks of diet feeding (n=8-11 per group). (C)
Representative photos of wild-type (WT) and Nedd4+/- (Het) male mice fed a ND or a
HFD at 22 weeks of age. All data are mean ± SEM; ***P<0.001.
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30.6 ± 1.0 g weight gain, 12 g less than the wild-type controls, in Nedd4+/- mice on HFD
(Figure 3.2B). Representative picture of the mice were shown in Figure 3.2C.
Nonetheless, Nedd4+/- mice had unaltered physical activity, thermogenesis-related
gene expression in BAT, and consumed calories proportional to their body weights.
Therefore, activity and metabolism cannot explain the difference in HFD-induced weight
gain between Nedd4+/- and control mice (Figure 3.3).
To determine if the reduced weight gain was due to decreased body length, we
measured the length of mice from anus to nose when the mice were anesthetized or
euthanized, which allows their bodies to stay in a relaxing posture. The average ‘anus-tonose’ lengths in gender-matched littermate Nedd4+/- and wild-type mice were similar on
HFD (Figure 3.4A), suggesting that Nedd4+/- mice are leaner rather than smaller.
Representative anatomical pictures of mice and dissected fat depots were shown in
Figure 3.4B. Postmortem dissection for epididymal, inguinal subcutaneous white, and
interscapular brown fat depots revealed significantly reduced accumulation of visceral
and subcutaneous fat but not interscapular brown fat in HFD-fed Nedd4+/- mice compared
to controls (Figure 3.4C). Ratios of epididymal and inguinal subcutaneous WAT mass
vs. body mass were ~36% lower in Nedd4+/- (4.5 ± 0.5% and 2.8 ± 0.4%) relative to
control mice (7.0 ± 0.1% and 4.4 ± 0.5%) on HFD (P<0.05) (Figure 3.4D and E). In
addition, the leptin mRNA levels in epididymal WAT were 32.5% lower in Nedd4+/- mice
(P<0.05) (Figure 3.4F), consistent with leptin as an indicator of body fat (Caro et al.,
1996). We estimated the lean body mass index by the weight of non-fat tissues, such as
the liver, heart, kidney, brain, and skeletal muscle (i.e., gastrocnemius and quadriceps),vs.
body weight. Our data show that the ratio of lean body mass vs. body mass were similar
between genotypes (Figure 3.4H).
On the ND, the ratios of lean body mass vs. body mass were similar between
Nedd4 and wild-type mice (Figure 3.4G). The observed lack of apparent decrease in
the weight gain in Nedd4+/- mice on ND (Figure 3.2A) was most likely because their
increase in lean body mass compensated for the decrease in fat mass; fat mass only
accounts for a small portion of body mass prior to middle age. These observations
suggest that protection of Nedd4+/- mice from diet-induced obesity, and even age-induced
obesity potentially, could have resulted primarily from the reduced fat mass.
+/-

3.2.3 Nedd4-haploinsufficient Mice Are Resistant to Several HFD-induced
Deleterious Effects without Changes in Serum Lipid Profile
The expansion of WAT in obesity can be a result of adipocyte hypertrophy
(increase in cell size) and/or hyperplasia (increase in cell number) (de Ferranti and
Mozaffarian, 2008; Sun et al., 2011). Histological analysis in the paraffin embedded
epididymal WAT revealed a significant 25% smaller average cell size in Nedd4+/- mice
on HFD (Figure 3.5A and B). Cell size distribution analysis showed a greater frequency
of small and midsized adipocytes and a lower frequency of large adipocytes in
epididymal WAT from the HFD-fed Nedd4+/- mice, while the distribution curves in the
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Figure 3.3 Nedd4-haploinsufficient Mice Exhibit Normal Physical Activity, Energy
Intake, and Thermogenesis-related Gene Expression.
(A) Mice at ages 12-16 weeks were fed a known amount of food ad libitum. After 24 hr,
the remaining food was weighed. Consumption of food (absolute food intake) was
calculated by the difference. Food intake was monitored on a daily basis for a continuous
7-day period. Food intake was converted to energy intake by multiplying by the energy
density in food. (B) Relative food intake was calculated as the absolute food intake per
gram of body weight. (C and D) Animals were individually placed for 10 min in a novel
open-field box equipped with beams that automatically measure total locomotor activity
by beam breaks. (C) Total number of beam breaks indicates total activity. (D) Total
distance traveled in inches. ND, n=14-23 per group; HFD, n=8-10 per group. (E) Relative
mRNA levels of thermogenic genes in BAT in littermates WT and Het on ND or HFD
were measured by qRT-PCR (ND, n=3 per group; HFD, n=5-6 per group). Data represent
mean ± SEM; * P<0.05; n.s. no significance.
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Figure 3.4 Nedd4-haploinsufficient Mice on HFD Have Reduced Fat Mass.
(A) Average ‘anus-to-nose’ lengths in gender-matched wild-type (WT) and Nedd4+/-(Het)
littermates. n=5 per group. (B) Representative anatomical views of mice fed a HFD. (C)
Epididymal (Epi) and inguinal subcutaneous (SubQ) fat pads were dissected from WT
and Het mice on ND or HFD. (D) Epi, SubQ and BAT depot weights in gender-matched
littermates WT and Het at 22 weeks of age. (E) Percentage of fat pad weights to the body
weights. n=5-7 per group. (F) Leptin mRNA levels in Epi by qRT-PCR analysis (ND n=3
per genotype; HFD n=5-6 per genotype). (G and H) Percentage of organ weights to the
body weights on ND (G) or on HFD (H) (n=5-7 per group). All data are mean ± SEM;
*P<0.05, **P<0.01 and ***P<0.001.
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Figure 3.5 Nedd4-haploinsufficient Mice Are Protected against HFD-induced
Adipocyte Hypertrophy.
(A) Representative H&E staining of adipocytes. (B-D) Mean (B) and distribution (C and
D) of adipocyte size in epididymal adipose tissue of wild-type (WT) and Nedd4+/- (Het)
littermates on ND (C) or HFD (D) (n=3-4 per group). The area of adipocytes was
measured for 300-400 cells per mouse using ImageJ software with “Adipocytes Tools”
plug-in. Scale bar=100 ȝm. All data are mean ± SEM; *P<0.05, **P<0.01, *** P<0.001.
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ND-fed Nedd4+/- and wild-type mice were almost overlapping (Figure 3.5C and D).
Hence, NEDD4 downregulation in obese mice was associated with reduced adipocyte
volume indicating lower degrees of lipid accumulation within adipocytes.
Chronic HFD leads to TG accumulation in liver called non-alcoholic fatty liver or
hepatic steatosis (Motomura et al., 2006). After 16 weeks of HFD, hepatocytes of wildtype mice were filled with multiple large lipid droplets, whereas Nedd4+/- littermates
displayed significantly smaller and fewer lipid droplets as detected by hematoxylin and
eosin stain or oil red O stain (Figure 3.6A and B). These data indicate protection from
hepatic steatosis in Nedd4+/- mice.
Low-grade inflammation invariably accompanies significant obesity (Wellen and
Hotamisligil, 2003). As expected, we saw dramatic HFD induced increases in mRNA
levels of several pro-inflammatory markers (MIP-Į0&3-71)Į)DQG,/-ȕ 
within the WAT of wild-type mice. TNF-ĮDQG)DUH0PDFURSKDJHPDUNHUVDQG
MIP-ĮDQG0&3-1 represent two major chemokines essential for recruiting M1
macrophages (Mantovani et al., 2004). The observed lower transcriptional expression of
these markers in HFD-fed Nedd4+/- mice compared to wild-type littermates may indicate
reduced M1 macrophage infiltration in the HFD-fed Nedd4+/- mice. IL4 and antiinflammatory IL10, two TH2 cytokines, can induce M2 macrophage polarization
(Mantovani et al., 2004). Interestingly, IL4 and IL10 mRNA levels were not significantly
different in WAT between genotypes, suggesting that the attenuation of lipid-induced
inflammation may be independent of M2 action (Figure 3.7). This is consistent with the
FHOOVL]HGLVWULEXWLRQGDWDWKDWVPDOODGLSRF\WH ȝP2) percentages in HFD-fed
Nedd4+/- and wild-type mice were similar (Figure 3.5D), since M2 macrophages mainly
present in lean adipose tissue (Fujisaka et al., 2009). Of note, NEDD4 protein levels per
se were unaltered by HFD in WAT, skeletal muscle, or hypothalamus (Figure 3.8A-C).
Dietary obesity is usually accompanied with enhanced basal lipolysis, resulting in
increased serum cholesterol, TG, glycerol, and FFA levels. However, we found unaltered
serum lipid profile in ND- or HFD-fed Nedd4+/- mice relative to their respective controls
(Table 3.1).
3.2.4 Nedd4-haploinsufficient Mice Retain Insulin Sensitivity in WAT despite HFD
To examine whole body insulin sensitivity, we performed GTT and ITT on ageand gender-matched mice at approximately age 22 weeks. In ND-fed Nedd4+/- vs.
controls, we observed decreased insulin sensitivity during ITT (Figure 3.9B) and a small
compensatory increase in the serum insulin levels under both fed (3.65 ± 0.28 ng/mL vs.
2.77 ± 0.27 ng/mL, P<0.01) and fasted (1.11 ± 0.10 ng/mL vs. 0.73 ± 0.08 ng/mL,
P<0.01) states (Figure 3.9D and E). Consistently, serum insulin levels in ND-fed
Nedd4+/- during GTT is slightly higher than that in the wild-type mice (P<0.05) (Figure
3.9C). Despite these defects, ND-fed Nedd4+/- mice were paradoxically glucose tolerant
with normal basal blood glucose level (Figure 3.9A). Collectively, the data suggest that
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Figure 3.6 Nedd4-haploinsufficient Mice Are Protected against HFD-induced
Hepatic Steatosis.
(A) Representative H&E staining of liver in littermates wild-type (WT) and Nedd4+/(Het) on ND or HFD (n=3). Sections were stained with hematoxylin for nuclei and
counterstained with eosin. (B) Representative oil red O staining in liver sections from
WT and Het mice on ND or HFD (n=3). Fixed cryosections were stained with freshly
prepared oil red O working solution for 15 min and counterstained for nuclei with
hematoxylin. Scale bar=100 ȝm.
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Figure 3.7 Nedd4-haploinsufficient Mice Are Protected against Lipid-induced
Inflammation.
Relative transcriptional levels of inflammatory markers in epididymal fat in littermates
wild-type (WT) and Nedd4+/- (Het) on ND or HFD were measured by qRT-PCR. ND n=3
per genotype; HFD (n=5-6 per genotype). Around 50 mg of adipose tissue was lysed in 1
ml of Trizol for RNA isolation. Around 1 ȝg of total RNA was reverse transcribed into
cDNAs which were subsequently used for qRT-PCR detection with intron-spanning
primers. All data are mean ± SEM; *P<0.05, **P<0.01.
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Figure 3.8 NEDD4 Protein Levels Are Not Altered by HFD Feeding.
Immunoblot analysis of NEDD4 protein levels in epididymal WAT (A), gastrocnemius
muscle (B) and hypothalamus (C) tissue lysates from WT mice fed on ND or HFD at age
36 weeks. The IRȕ levels in WAT served as a positive control of the effect of HFD. The
GAPDH levels served as loading controls.
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Table 3.1 Metabolic Parameters in Serum or Blood.
WT, ND
Measurements
Mean ± SEM
Glucose (mM)
Fed
11.46 ± 0.49
Fasted
8.02 ± 0.57
Cholesterol (mM)
Fed
4.30 ± 0.37
Fasted
2.87 ± 0.50
TG (mM)
Fed
2.26 ± 0.31
Fasted
1.83 ± 0.18
Glycerol (mM)
Fed
3.87 ± 0.32
Fasted
4.92 ± 0.44
FFA (mM)
Fed
0.20 ± 0.02
Fasted
0.17 ± 0.04

n

Het, ND
Mean ± SEM

n

Statistics

WT, HFD
Mean ± SEM n

Het, HFD
Mean ± SEM n

12
12

11.84 ± 0.36
8.73 ± 0.37

12
12

n.s.
n.s.

12.95 ± 0.43
10.29 ± 0.38

12
12

13.24 ± 0.56
9.52 ± 0.79

12
12

n.s.
n.s.

10
10

4.40 ± 0.31
2.65 ± 0.62

10
10

n.s.
n.s.

6.37 ± 0.45
3.48 ± 1.07

10
10

6.73 ± 0.45
2.20 ± 1.41

10
10

n.s.
n.s.

10
10

2.65 ± 0.21
1.81 ± 0.20

10
10

n.s.
n.s.

2.74 ± 0.20
2.33 ± 0.39

10
10

2.79 ± 0.35
2.53 ± 0.68

10
10

n.s.
n.s.

8
8

3.86 ± 0.29
5.25 ± 0.31

7
7

n.s.
n.s.

6.01 ± 0.35
5.05 ± 0.63

9
9

5.85 ± 0.52
3.76 ± 0.59

6
6

n.s.
n.s.

8
8

0.20 ± 0.02
0.17 ± 0.03

7
7

n.s.
n.s.

0.28 ± 0.02
0.18 ± 0.07

9
9

0.28 ± 0.02
0.18 ± 0.08

6
6

n.s.
n.s.

Statistics

Notes: Blood glucose and lipid levels in serum from fed and fasted mice were measured by a glucose meter or respective assay kits.
Fed glucose levels are higher in HFD groups compared to respective group on ND (WT, P<0.05; Nedd4+/-, P<0.05). Fasting glucose
and TG levels are higher in WT, HFD compared to WT, ND (P<0.01). Fed cholesterol, TG, glycerol, and FFA levels are higher in
HFD groups compared to respective group on ND (WT, P<0.001; Nedd4+/-, P<0.001). Each group contains relatively equal numbers
of male and female. Mice were tested around 22 weeks of age. WT, wild-type mice; Het, Nedd4+/- mice. All data are means ± SEM;
n.s. no significance.
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Figure 3.9 GTT, ITT, and Serum Insulin Levels.
(A) No significant difference in glucose clearance ability between two genotypes (n=1219 per group). (B) Under normal diet (ND), Nedd4+/- (Het) mice were less responsive to
insulin compared to wild-type (WT) littermate controls based on glucose clearance rate
(n=12-19 per group). (C) Serum insulin levels during GTT (n=12-19 per group with both
genders). For GTT, mice were fasted overnight and i.p. injected with 1.5 g/kg of glucose.
For ITT, mice were fasted for 4 hr and i.p. injected with 0.75 U/kg of insulin. Fed (D)
and fasted (E) serum insulin levels in WT and Het mice on ND or HFD. All data are
mean ± SEM; *P<0.05, **P<0.01, ***P<0.01.
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ND-fed Nedd4+/- mice possess only mildly decreased insulin sensitivity, which can be
compensated by increased insulin secretion.
In wild-type mice, HFD induced profound glucose intolerance, insulin resistance
associated with a five-fold increase in the basal circulating insulin concentration, and
failure of glucose-stimulated insulin secretion (Figure 3.9A-C). Most surprising,
chronically HFD-fed Nedd4+/- mice displayed same degree of glucose intolerance (Figure
3.9A and B) despite lower circulating insulin levels (Figure 3.9C-E), compared to HFDfed controls (fed, 9.23 ± 0.69 ng/mL vs. 11.8 ± 0.65 ng/mL, P<0.05; fasted, 5.19 ± 0.72
ng/mL vs. 8.03 ± 0.99 ng/mL, P<0.05) , suggesting that the HFD-fed Nedd4+/- mice
required less circulating insulin to maintain euglycemia.
To delineate insulin sensitivity in specifically responsive tissues, we analyzed
insulin-stimulated signaling in WAT, skeletal muscle, and liver. Western blot analysis of
in vivo insulin signaling in fat, skeletal muscle, and liver demonstrated reduced
phosphorylation of IR and protein kinase B/AKT (PKB/AKT) evoked by a single i.p.
insulin injection in ND-fed Nedd4+/- mice (Figure 3.10A-C). Nedd4+/- mice on HFD
displayed enhanced tyrosine phosphorylation of IR and their downstream PK B/AKT
only in WAT (Figure 3.10D), but not in skeletal muscle or liver (Figure 3.10E and F).
3.3 Summary
NEDD4 is a HECT-type E3 ligase that has been implicated in the downregulation
of several activated receptor tyrosine kinases in vitro. Genetic knockout of NEDD4 led to
reduced IGF-1 signaling, suggesting that the role of NEDD4 in this system is more
complex. Because NEDD4 knockout mice have major embryonic defects, most of the
current studies regarding NEDD4 function are restricted to mouse embryonic
development. We found that Nedd4+/- mice were devoid of gross morbidity or mortality
and therefore can be used for investigating NEDD4 function in adult and/or aging stage.
Our preliminary studies confirmed several reported substrates of NEDD4 in neuronal
culture system, such as PTEN and IGF-1R, both of which have central functions in
insulin/IGF-1 signaling. To study the NEDD4’s role in metabolic regulation, we
challenged Nedd4+/- mice with a HFD (60% of calories from fat) for 30 weeks. By
monitoring their body weights weekly, we found a significant difference in weight gain
between Nedd4+/- and wild-type mice.
Further characterization revealed that the loss of HFD-provoked weight gain in
Nedd4+/- mice was due to reduced fat content, especially the mass of visceral and
subcutaneous fat. Although the absolute weights of other non-fat organs were lower in
Nedd4+/- mice than in controls, their weights were in proportion to their total body
weights. Histological analysis of adipose tissue showed smaller adipocyte size in Nedd4+/mice. The associated complications, such as lipid-induced hepatic steatosis and
inflammation, were also attenuated in HFD-fed Nedd4+/- mice. These data suggest that
Nedd4+/- mice have better ability to attain fat balance upon energy surplus, and therefore,
resist to obesity development.
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Figure 3.10 In vivo Insulin Signaling in WAT, Skeletal Muscle, and Liver.
Western blot analysis of phosphorylated and total IRȕ and AKT protein levels in WAT
(epididymal) (A and D), skeletal muscle (gastrocnemius) (B and E), and Liver (C and F)
in wild-type (WT) and Nedd4+/- (Het) mice on ND (A-C) or HFD (D-F) with protein
quantification (n=5-7 per group).Mice at age around 22 weeks were fasted overnight and
i.p. injected with 5 U/kg of insulin and waited for 15 min before being euthanized.
Tissues were quickly dissected and snap-frozen until use. All data are mean ± SEM;
*P<0.05, **P<0.01.
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In response to HFD, partial loss of NEDD4 function was associated with reduced
circulating insulin levels and selective insulin sensitivity improvement in WAT, but not
in skeletal muscle or liver, despite unalleviated systemic impairment in glucose
homeostasis. These data suggest that NEDD4 may partially mediate obesity-associated
insulin resistance. Paradoxically, NEDD4 was required for maintaining normal insulin
signaling under basal conditions (fed on ND), as Nedd4+/- mice on ND displayed reduced
insulin signaling in several insulin-sensitive organs (WAT, skeletal muscle, and liver).
Taken together, these data imply that NEDD4 may have distinct physiological and
pathophysiological roles in insulin system.
In addition to glucose tolerance, Nedd4+/- mice exhibited similar serum lipid
concentrations to those of control mice with or without HFD challenge, suggesting that
NEDD4 has minor roles in regulating glucose homeostasis and blood lipid turnover.Also,
HFD did not affect NEDD4 expressional levels in several metabolic tissues
(hypothalamus, skeletal muscle, WAT).
In summary, Nedd4 haploinsufficiency protects against HFD-induced obesity,
hyperinsulinemia, adipocyte hypertrophy, hepatic steatosis, and pro-inflammatory
response. However, partial loss of NEDD4 function does not alleviate obesity-associated
insulin resistance, glucose intolerance, and hyperlipidemia, decoupling obesity from
several of its associated pathologies. Although the reason why Nedd4+/- mice manifest
these decoupling effects is unclear, our studies may provide experimental evidence for
clinical heterogeneity seen in metabolic syndrome.
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CHAPTER 4.

MECHANISTIC STUDIES
4.1 Introduction

E3 ligases that possess the ability of selecting specific proteins for ubiquitin
conjugation are important regulators in protein degradation process. NEDD4 is the
prototypic member in NEDD4 protein family of E3 ligases which contains a C2 domain,
3-4 WW domains, and a catalytic HECT domain. During the process of ubiquitination,
the ubiquitin-conjugated E2 binds to the C-terminal HECT domain, initiating a thiol-ester
exchange to transfer the ubiquitin from E2 to a catalytic cysteine residue within the Cterminal lobe of the HECT domain (Ingham et al., 2004). HECT domain, therefore,
transiently receive ubiquitin before its transfer to the substrate. Repetitive occurrence of
this thiol-ester exchange produces a polyubiquitin chain which targets the substrate
protein for lysosomal or proteasomal degradation (Wang et al., 1999a). While the C2
domain regulates cellular translocation of NEDD4, the multiple WW domains which bind
predominantly to proline-rich motifs (PPxY, PPLP, PR, and phosphoserine/threonine
residues that precede a proline residue) are mainly responsible for substrate selection by
NEDD4 (Ingham et al., 2004).
Two mammalian non-visual arrestins (ȕ-arrestin 1 and 2) and the arrestin domaincontaining proteins (ARRDC2-4) have been reported to function primarily as adaptor
proteins between E3 ligase NEDD4 and ȕ2-AR (Han et al., 2013b). No proline-rich
motifs were found in ȕ-arrestins; mutation in WW domains of NEDD4 did not affect the
recruitment of NEDD4 to ȕ2-AR, suggesting that non-canonical binding exists between
1(''DQGȕ-arrestins (Shenoy et al., 2008). Unlike ȕ-arrestins, a PPxY motif was
found in ARRDCs. The ARRDC3 protein interacts with NEDD4 through two conserved
PPxY motifs (Nabhan et al., 2010). Interestingly, ARRDC3-deficient mice also displayed
SDUWLDOUHVLVWDQFHWRREHVLW\SUHVXPDEO\YLDPRGXODWLQJȕ-adrenergic signaling (Patwari et
al., 2011)
In Chapter 3 we have carefully characterized the metabolic phenotypes in
Nedd4 mice. We found that Nedd4+/- mice after HFD feeding elicited reduced adiposity,
due mainly to the smaller visceral and subcutaneous fat depots. In the current chapter, we
seek to investigate the underlying mechanisms. We examined whether the lipolytic
efficiency was altered in HFD-fed Nedd4+/- mice as they manifested reduced lipid storage
and tKHȕ2-AR is an essential mediator of lipolysis process in fat. Here, we also
investigated potential regulation of 33$5Ȗ by NEDD4. Because it has been widely
accepted that PPARȖ plays fundamental regulatory roles in adipose tissue biology and
pathology: 33$5ȖPHGLDWHV not only adipogenesis but also HFD-induced adipocyte
hypertrophy (Kubota et al., 1999), two important processes controlling adipose tissue
volume.
+/-
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4.2 Results
4.2.1 Knockdown of NEDD4 Accelerates Lipolysis
Lipolysis rate in response to i.p. injection of isoproterenol (a non-VHOHFWLYHȕ-AR
agonists) in vivo was similar between ND-fed Nedd4+/- and wild-type mice. However, the
lipolysis rate in the HFD-fed Nedd4+/- mice was significantly higher than controls
(Figure 4.1A). To confirm this in vivo finding, we assayed lipolysis ex vivo in purified
primary adipocytes. Whereas HFD greatly inhibited the isoproterenol-stimulated glycerol
release in wild-type adipocytes, Nedd4+/- adipocytes remained highly sensitivHWRȕ-AR
stimulation. Furthermore, preincubation with insulin (a potent anti-lipolytic hormone) of
primary adipocytes isolated from HFD-fed Nedd4+/- mice completely blocked
isoproterenol-stimulated glycerol release. This effect was not observed in controls and
was consistent with respective levels of insulin signaling in WAT7RDVVHVVZKHWKHUȕ1$5DQGRUȕ2-AR mediated this effect, we preincubated the adipocytes with ICI-118,551
DVHOHFWLYHȕ2-AR antagonist) or CGP-20 DVHOHFWLYHȕ1-AR antagonist). ICI-118,551
completely blocked the isoproterenol-stimulated lipolytic response observed in primary
adipocytes derived from HFD-fed Nedd4+/- mice. CGP-20712 attained only partial
LQKLELWLRQRIOLSRO\VLVVXJJHVWLQJWKDWȕ2-AR primarily mediates the enhancement of
isoproterenol-induced lipolysis related to NEDD4 loss of function. In addition, treating
SULPDU\DGLSRF\WHVZLWKRWKHUVHOHFWLYHȕ1-$5RUȕ2-AR agonists (xamoterol and
VDOPHWHUROUHVSHFWLYHO\ FRQILUPHGȕ2-AR as the predominant mediator (Figure 4.1B).
As mice age, their growth rates decrease and fatty acids are largely stored in the
adipose tissue in the form of TGs, mimicking hyperlipidemia in clinical obesity. To
investigate the effect of age on lipolysis, a set of age- and gender-matched Nedd4+/- and
wild-type mice were placed on ND, then followed to age roughly 18 months. We
obtained epididymal fat tissue explants or purified primary adipocytes to assess lipolysis
ex vivo. Isoproterenol stimulated significantly higher lipolysis in fat explant from aged
Nedd4+/- mice, as early as 30 min after incubation (Figure 4.1D). Isoproterenol and
salmeterol, but not xemoterol, stimulated higher lipolysis rates in adipocytes from aged
Nedd4+/- mice, confirming accelerated lipolysis in aged Nedd4+/- mice and a primary role
IRUȕ2-AR in this regulation (Figure 4.1C).
4.2.2 .QRFNGRZQRI1('',QFUHDVHVȕ2-AR Abundance at the Plasma Membrane
3URORQJHGVWLPXODWLRQZLWKDJRQLVWVKDVEHHQVKRZQWRGRZQUHJXODWHȕ2-AR, via
endocytosis and the subsequent lysosomal degradation of active receptors. Recent work
based on in vitro overexpression suggests NEDD4 is an E3 ligase involved in ȕ2-AR
protein degradation (Nabhan et al., 2010; Shenoy et al., 2008). To validate the
SK\VLRORJLFDOLPSDFWRI1(''RQȕ2-AR regulation in vivo —in the context of
lipolysis,—ZHILUVWH[DPLQHGZKHWKHU1(''NQRFNGRZQLQFUHDVHVȕ2-AR abundance.
Whole cell lysates and crude membrane fractions prepared from WAT from HFD-fed
Nedd4+/- and wild-type mice were analyzed by immunoblot. Despite only a 1.4-fold
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Figure 4.1 Downregulation of NEDD4 Enhances Hormone-stimulated Lipolysis In
vivo and Ex vivo.
(A) Serum free glycerol levels in a cohort of 22-week-old, gender-matched wild-type
(WT) and Nedd4+/- (Het) mice at indicated time after i.p. isoproterenol, 10 mg/kg (n=5).
(B) Primary adipocytes purified from epididymal fat of WT and Het mice were
resuspended in media and incubated with indicated reagents with gentle shaking for 1 hr.
Insulin, ȕ-DJRQLVWVDQGȕ-antagonists were pre-incubated for 10 min. Glycerol levels in
conditioned media were measured (n=4). (C) Primary adipocytes were purified from
epididymal fat of aged WT and Het mice and resuspended in media with indicated
reagents. Glycerol levels in media were measured after 1-hr incubation (n=5-6). (D)
Adipose tissue explants from aged WT and Het mice were resuspended in DMEM
supplemented with 0.5% fatty acid free BSA and shaken at 400 rpm at 37°C with or
ZLWKRXWȝ0LVRSURWHUHQROIRUKr. Glycerol levels were normalized to the weights of
adipose tissue explant (n=4). Data represent mean ± SEM; *P<0.05, **P<0.01, and
***P<0.001.
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LQFUHDVHLQWRWDOȕ2-AR protein levels (Figure 4.2A), a dramatic 2.4-fold increase in
PHPEUDQHȕ2-AR levels was detected (Figure 4.2B). These observations suggest that the
enhanced lipolysis associated with NEDD4 reduction is likely due to increased
DEXQGDQFHRIȕ2-$5RQWKHDGLSRF\WHSODVPDPHPEUDQH:HIDLOHGWRGHWHFWȕ1-AR in
these experiments, owing to high background with the chosen antibody. Concurrently, we
observed a 1.5-fold higher level of IR, but not IGF-1R, on the plasma membrane in
Nedd4+/- mice on HFD (Figure 4.2B), consistent with the observations of elevated insulin
signaling in WAT.
To confirm these observations in vitro, we employed HEK293 cells with stable
HFWRSLFRYHUH[SUHVVLRQRIKXPDQȕ2-AR at a medium level. Downregulation of membrane
ȕ2-AR by prolonged isoproterenol incubation was largely rescued by either NEDD4
knockdown or transient overexpression of a dominant negative NEDD4 (a CS mutant
lacking E3 ligase activity) (Figure 4.2C).
4.2.3 Knockdown of NEDD4 Increases Lipolytic but Inhibits Adipogenic Response
in 3T3-L1 Adipocytes
NEDD4 is present at high concentration in 3T3-L1 cells. The 3T3-L1 cell line is
one of the most hard-to-transfect cell lines. Therefore, it is technically difficult to
completely deplete NEDD4 from 3T3-L1 cells. Using adeno-associated virus (AAV)delivery of specific shRNA targeting Nedd4 mRNA (EGFP-tagged), we were able to
downregulate both Nedd4 mRNA and NEDD4 protein levels by ~50% (Figure 4.3C).
Knocking down NEDD4 in 3T3-L1 adipocytes produced a subtle but significant increase
in isoproterenol-stimulated lipolysis. These data suggest that the enhanced lipolytic
responses observed in HFD-fed or aged Nedd4+/- mice are most likely a direct result of
NEDD4 downregulation and not a secondary (endocrine) effect from other organs. Since
3T3-/DGLSRF\WHVH[SUHVVSUHGRPLQDQWO\ȕ2-VXEW\SH$5WKHVHGDWDLPSO\WKDWȕ2-AR is
regulated by NEDD4 in adipocytes (Figure 4.3A).
Another intriguing finding was that knocking down NEDD4 in 3T3-L1 cells by
AAV-delivered shRNA greatly impeded the efficiency of the preadipocyte-to-adipocyte
conversion (Figure 4.3B 33$5Ȗ is arguably the central regulator of adipogenesis. To
H[DPLQHZKHWKHU1(''DIIHFWV33$5Ȗ levels, we PHDVXUHG33$5ȖH[SUHVVLRQLQ
shNEDD4 AAV-infected 3T3-L1 adipocytes. Strikingly, we found a similar degree
(~50%) of PPARȖ downregulation to NEDD4 reduction (P<0.001) (Figure 4.3C),
together with a consistent ~12% reduction in the mRNA levels for aP2 and Cebpa, two
33$5ȖGRZQVWUHDPWDUJHWJHQHV. 'HVSLWHWKHGHFUHDVHLQ33$5ȖSURWHLQThe Pparg
mRNA levels were not altered in comparison to those infected with scrambled shRNA
AAV (Figure 4.3D). At terminal differentiation, there were still approximately 50% of
the cells expressing EGFP-tagged shRNA viruses (Figure 4.3E).
7RH[DPLQHZKHWKHU1(''DIIHFWV33$5ȖOHYHOV in vivoZHPHDVXUHG33$5Ȗ
expression in epididymal WAT. Western blot analysis revealed a trend of reduction in the
SURWHLQOHYHOVRIERWK33$5ȖLVRIRUPV EXWQRW&(%3Į in both HFD-fed and aged
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Figure 4.2 Loss of NEDD4 Function IQFUHDVHVȕ-AR Protein Concentration at
Plasma Membrane.
(A) Representative Western EORWIRUȕ2-AR expression in epididymal WAT of wild-type
(WT) and Nedd4+/- (Het) mice after HFD (n=4). (B) Representative Western blot for
crude membrane fraction from primary adipocytes purified from WT and Het mice after
HFD (n=3). & ȕ2-AR-Flag overexpressing cells were transfected with control shRNA
(shControl), NEDD4 shRNA (shNEDD4), NEDD4 WT, or NEDD4 CS mutant. After 24KULQFXEDWLRQZLWKȝ0LVRSURWHUHQROFUXGHPHPEUDQHIUDFWLRQVZHUHSUHSDUHGIRU
Western blot. Data represent three independent experiments. Data represent means ±
SEM; * P<0.05, ** P<0.01.
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Figure 4.3 Partial Loss of NEDD4 Function Increases Lipolytic but Inhibits
Adipogenic Response.
(A) 3T3-L1 adipocytes were infected with AAV virus for expressing shRNA sequences
targeting NEDD4 (shNEDD4) or non-targeting shRNA control (shControl), then
incubated with indicated reagents for 1 hr. Conditioned media were collected and
centrifuged to remove cell debris. Glycerol concentrations in the media were measured.
Data represent three independent experiments. (B) 3T3-L1 cells were infected with
shControl-AAV or shNEDD4-AAV and induced to differentiation as described in
Chapter 2. Differentiated adipocytes were stained with oil red O and photographed. (C
and D) Representative Western blot (C) and qRT-PCR (D) analysis in 3T3-L1 adipocytes
infected with indicated virus. Data represent four independent experiments. (E)
Differentiated adipocytes were stained with oil red O and photographed. At terminal
differentiation, there were still approximately 50% of the cells expressing EGFP. Data
represent mean ± SEM; *P<0.05, **P<0.01 and ***P<0.001.
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Nedd4+/- mice (Figure 4.4A and B). The qRT-PCR analysis did not detect significant
changes in the mRNA levels of these adipogenic transcription factors (Figure 4.4C).
To our surprise, 1(''GLGQRWGLUHFWO\PRGXODWH33$5ȖDFWLYLW\%DVHGRQD
33$5ȖOXFLIHUDVHUHSRUWHUDVVD\33$5ȖWUDQVDFWLYDtion by rosiglitazone was not altered
by NEDD4 knockdown, NEDD4 overexpression, or overexpression of a mutant NEDD4
(C854S) lacking E3 ligase activity (Figure 4.5). These data indicate that NEDD4 altered
33$5Ȗabundance at the protein level.
4.2.4 Knockdown of NEDD4 Destabilizes 33$5Ȗ Protein
Next, we tested the role of NEDD4 as a regulator of PPARȖ protein. Since
NEDD4 and PPARȖ expression are positively correlated, we hypothesized that NEDD4
acts as a stabilizer for PPARȖ protein. To test this hypothesis, we manipulated NEDD4
expression in HEK293 cells transiently overexpressing PPARȖ, and blocked the de novo
protein synthesis within the cells using cycloheximide. After 6 hr incubation, cells that
had reduced NEDD4 expression also had significantly lower PPARȖ concentration
(Figure 4.6A and C). NEDD4 or NEDD4-CS upregulation in cells protected PPARȖ
protein from degradation, with most dramatic effect within 4 hr (Figure 4.6B and D),
suggesting that the stabilization does not require the enzymatic function of NEDD4.
%\DQDO\]LQJ33$5Ȗ VHTXHQFHZHLGHQWLILHGD33[<PRWLIZLWKLQ33$5Ȗ that
could serve as a binding site for NEDD4 (Figure 4.7A ,QGHHG1(''DQG33$5Ȗ
could be pulled down together in overexpressed culture system demonstrating that these
proteins interact. The same interaction was found in 3T3-L1 adipocytes and mouse WAT
(Figure 4.7B-D). To inYHVWLJDWHZKHWKHUWKHLQWHUDFWLRQEHWZHHQ1(''DQG33$5Ȗ is
altered during adipogenesis, we co-immunoprecipitated these proteins from 3T3-L1 cell
lysates collected throughout differentiation. Remarkably, NEDD4-33$5Ȗ interaction was
the strongest in preadipocytes, then gradually weakened as differentiation continued
(Figure 4.8). The reciprocal changes observed in the NEDD4-PPARȖ interaction and the
33$5Ȗ levels during adipogenesis strongly suggest a central role for NEDD4 in
adipogenesis which warrants further investigation.
4.3 Summary
In this chapter, we studied potential molecular and cellular mechanisms that lead
to the "lean" phenotype in Nedd4+/- mice. As shown in the previous chapter, these mice
had normal energy intake and exhibited similar physical activity to wild-type mice. The
transcriptional expression of several key thermogenesis-related genes in BAT in Nedd4+/mice was also undistinguishable from that in wild-type animals, suggesting unaltered
thermogenesis.
Due to resource limitation, we did not examine the basal metabolic rates in these
mice, therefore, cannot rule out the contribution from basal metabolism. Nonetheless, we
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Figure 4.4 3DUWLDO/RVVRI1('')XQFWLRQ5HGXFHV33$5Ȗ/HYHOVLQWAT.
(A and B):HVWHUQEORWRI33$5ȖSURWHLQOHYHOVLQHSLGLG\PDOIDWIURPJHQGHU-matched,
HFD-fed, wild-type (WT) and Nedd4+/- (Het) littermates at age 22 weeks (A) and age 18
months (B) (A, n=7-8; B, n=6). (C) Relative transcriptional levels of aP2, C/EBPĮ and
33$5Ȗ in epididymal fat in littermate WT and Het mice on ND or HFD were measured
by qRT-PCR (ND, n=3, HFD, n=5-6). Data represent mean ± SEM; *P<0.05.
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Figure 4.5 NEDD4 Has No Direct EIIHFWRQ33$5ȖActivity.
HEK293 cells were seeded in a 24-well plate and left overnight for attachment. Each well
was transiently co-transfected with 250 ng 3 hPPRE-Luc, 250 ng 33$5Ȗ2-Flag, 10 ng
Renilla luciferase control reporter vector pRL-SV40 and 250 ng plasmids indicated under
each column. After 32 hr of transfection, cells were treated with or without rosiglitazone
(10 ȝM) for 16 hr prior to luciferase assay. Luciferase activity was normalized to Renilla
activity as a control for transfection efficiency. Data represent three independent
experiments.

51

Figure 4.6 NEDD4 SWDELOL]HV33$5ȖProtein Expression In vitro.
HEK293 cells were seeded in a 6-well plate and left overnight for attachment. Each well
was transiently co-transfected with 1 ȝg PPARȖ-Flag and 1 ȝg indicated plasmids. After
48 hr, cells were incubated with 20 ȝM of cycloheximide (CHX) for 2, 4, and 6 hr. (A
and B) Representative Western-blot image of PPARȖ protein levels during CHX-chase
experiment. (A) NEDD4 knockdown by shRNA. (B) NEDD4 or NEDD4 CS mutant
overexpression. (C) Quantification data for the effect of NEDD4 knockdown on PPARȖ
protein levels. (D) Quantification data for the effect of NEDD4 or NEDD4 CS mutant
overexpression on PPARȖ protein levels. Data represent three independent experiments.
Data represent mean ± SEM; *P<0.05, **P<0.01; n.s., no significance.
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Figure 4.7 NEDD4 Interact with 33$5Ȗ.
(A) Sequence alignment of PPxY motif ZLWKLQ33$5Ȗ in various species. (B) CoimmunoprecipitatLRQRI33$5ȖLQ7-L1 adipocytes with 1 ȝg of anti-33$5Ȗ antibody
(E8, Santa Cruz) and 500 ȝg of extract. Co-IP using normal mouse IgG served as
negative control. (B) Co-immunoprecipitatLRQRI1(''RU33$5ȖLQ+(.FHOOV
transiently overexpressing plasmids containing NEDD4 and 33$5Ȗ2 with respective
antibodies. Lysates pulled down with anti-IgG served as negative control. (D) Coimmunoprecipitation of NE''RU33$5ȖLQ500 ȝg protein lysates of epididymal WAT
dissected from wild-type (WT) and Nedd4+/- (Het) mice.
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Figure 4.8 NEDD4-33$5Ȗ,QWHUDFWLRQ$OWHUDWLRQGXULQJ$GLSRF\WH&RQYHUVLRQLQ
3T3-L1 Cells.
(A) Oil red O staining on 3T3-L1 cells incubated with or without IDX cocktail (0.5 mM
IBMX, 1 ȝM dexamethasone, and 1.5 ȝg/mL insulin). Picture was taken at 7 days after
IDX treatment. (B) After indicated time of differentiation, 3T3-L1 cells were harvested,
immunoprecipitated with an antibody against PPARȖ (Santa Cruz E8), followed by
NEDD4 Western blot. Whole cell lysates (input) were immunoblotted for indicated
proteins. Co-IP antibody: 1 ȝg; extract: 500 ȝg; input: 20 ȝg. Data represent two
independent experiments.
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provide substantial evidence from in vivo and in vitro experiments implying that NEDD4
is a regulator of two important pathways in lipid metabolism, i.e. lipolysis and
adipogenesis, via modulating ȕ2-AR and PPARȖ functions. Isoproterenol stimulated more
glycerol release in Nedd4+/- mice and isolated Nedd4+/- adipocytes, suggesting enhanced
ȕ-adrenergic signaling. Data from the treatments of different ȕ agonists or co-incubation
of isoproterenol with specific ȕ antagonists suggested that ȕ2-AR primarily mediated the
enhanced lipolytic response by NEDD4 downregulation. Concurrently, Western blot
analysis of total and membranous ȕ2-ARs in adipose tissue revealed higher expression of
the receptor, especially membranous receptor in Nedd4+/- mice. NEDD4 knockdown or
overexpressing a dominant negative NEDD4 increased ȕ2-AR levels in crude membrane
fractions from HEK293 cells stably expressing Flag-ȕ2-AR. These data support a
previously identified NEDD4's role as an E3 ligase for ȕ2-AR protein degradation
(Shenoy et al., 2008).
Using 3T3-L1 cells as a model, we found that downregulation of NEDD4 in 3T3L1 preadipocytes inhibited their adipogenic response by the IDX cocktail. The protein
but not mRNA level of PPARȖ, a key adipogenic transcription factor, was also reduced in
NEDD4 knockdown 3T3-L1 cells. We confirmed this positive correlation between
NEDD4 and PPARȖ in vivo in WAT from both HFD-fed and aged mice. Overexpression
of NEDD4 stabilized ectopically expressed PPARȖ, while NEDD4 knockdown
destabilized it. This stabilization effect appeared to be independent of NEDD4's ubiquitin
ligase function, as overexpression of a dominant negative form of NEDD4 could stabilize
PPARȖ to similar extend as wild type NEDD4. Moreover, NEDD4 and PPARȖ could be
co-immunoprecipitated as a complex; their interaction was strongest in preadipocytes and
gradually attenuated during adipocyte conversion further indicating an important role of
NEDD4 in adipogenesis.
In summary, the delayed development of HFDIO in Nedd4+/- mice can be
explained at least through the NEDD4-mediated regulation of lipolysis and adipogenesis
pathways. These findings again support a novel role of NEDD4 in the molecular
pathophysiology of obesity.
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CHAPTER 5.

NEUROBEHAVIORAL ANALYSES
5.1 Introduction

Ubiquitin-mediated proteolysis, being undeniably important for most intracellular
processes, is increasingly recognized as a critical mechanism in the regulation of
neuronal development and function in the brain. In Chapters 3 and 4, we have studied
NEDD4’s role in metabolic function in the context of obesity. In the current chapter, we
will extend our investigation to NEDD4’s neuronal functionality.
A unique morphological feature of neurons is that they possess axons and
dendrites (collectively known as neurites), which are projections of neurons that serve to
transmit electrical/electrochemical signals. Neurons are connected to each other with
their neurites to form neural networks. Typically, a neuron propagates electrical signals
through its axon. At the axon terminal, electrical signals trigger release of
neurotransmitters which can be received by dendrites from other neurons. The axon
terminal, the receiving surface of dendrite, and the cleft in between constitute a synapse,
whose plasticity (i.e. synaptic plasticity) plays important role in learning and memory.
NEDD4 is highly expressed in mammalian neurons. Through modulation on its
neuronal substrates, it has been implicated in at least four aspects of neuronal physiology
—that is neurite outgrowth, neuron survival, ion channel functions, and neurotransmitter
signaling. Two studies in 2010 demonstrated an integral role of NEDD4 in the growth
and branching of neurites: Drinjakovic et al. reported that disrupting NEDD4 function
severely inhibits the terminal branching of retinal ganglion cell axons by downregulating
PTEN (Kawabe et al., 2010). Similarly, using both conventional and conditional NEDD4
knockout mice, Kawabe et al. identified NEDD4 as an important player in promoting
dendrite formation through inhibiting Rap2A function (Kawabe et al., 2010). In addition,
NEDD4 was involved in regulating neuronal survival via targeting PTEN for degradation
in neurons, as demonstrated previously in our laboratory (Kwak et al., 2010). Also,
NEDD4 was able to decrease whole cell Ca(v) currents by downregulating Ca(v) calcium
channels (Rougier et al., 2011) and to mediate agonist-dependent ubiquitination and
degradation of GluA1-containingĮ-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
receptor (AMPAR) (Schwarz et al., 2010). Most of these studies were conducted either in
vitro or at the embryonic stage, raising an interesting question about the NEDD4’s
neuronal physiological roles in postnatal life.
The sporadic Alzheimer's disease (AD), the most common form of dementia, has
been increasingly linked to T2D. Some even term AD as "type 3" diabetes, as many
observations in AD brains reflect similarities in T2D, such as insulin resistance and
reduced glucose utilization in the brain (Liao and Xu, 2009; Steen et al., 2005). In
addition, several lines of evidence indicate that boosting insulin signaling in the brain via
intranasal insulin administration improves cognition in AD patients(Benedict et al., 2004;
Craft et al., 2012; Dhamoon et al., 2009; Reger et al., 2008). One of the research interests
in our laboratories is to identify the molecular links between these two types of disease.
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Previous studies from our laboratory and others(Cao et al., 2008; Drinjakovic et al., 2010;
Kawabe et al., 2010; Kwak et al., 2012) demonstrated that NEDD4 is involved in
insulin/IGF-1 signaling, neurite development, and is likely implicated in AD progression,
as the expression levels of NEDD4 are increased in postmortem AD brains. Here, we
investigated whether heterozygous deletion of Nedd4 in mice can alter CNS metabolism
(insulin signaling, in particular) which may lead to neurobehavioral alteration in vivo.
5.2 Results
5.2.1 Nedd4-haploinsufficient Mice Have Improved Fear-associated Memory
Fear conditioning is an experimental paradigm to study fear associated memory.
Normally, animals are challenged with electric shocks paired with a certain context (e.g.
a room) and a certain cue (e.g. a tone). After a period of time, the fear response of
animals (freezing) is tested when re-exposed to the same context or cue. This is a form of
learning and memory mainly dependent upon a brain region called amygdala. But the
contextual fear conditioning is believed to involve also hippocampus (Phillips and
LeDoux, 1992). When exposing to foot shock, Nedd4+/- and control mice displayed
similar immediate freezing response, indicating that there is no difference in their
threshold for pain (Figure 5.1A). After 24 hr, we placed these mice individually in boxes
with changed context (decoration and bedding), played the same cue again as on day 1,
and recorded their freezing time. The result showed no significant difference in cued fear
conditioning (Figure 5.1B). Another 3 hr after tone test, we placed these mice back in
exactly the same box as on the training day. The Nedd4+/- mice showed higher freezing
response than their wild-type littermates (1.4-fold, P<0.01), suggesting better fearassociated memory in the Nedd4+/- mice (Figure 5.1C).
5.2.2 Nedd4-haploinsufficient Mice Display More Spontaneous Alternation
The cross maze is a behavioral test commonly used for assessing animals’ spatial
learning and memory, which is believed to depend on the function of hippocampus
(Lalonde, 2002). Rodents possess a strong tendency on arm alternation, which is they
prefer to explore new arms. The “smart” mice should remember which maze arm was last
visited. Therefore, recording the orders of their entries is used as an index of the spatial
reference memory. We placed a cohort of Nedd4+/- and wild-type mice individually in a
standard cross maze and recorded their order of arm entries. At the end of the test, the
total number of arm entries and alternation were analyzed. Interestingly, the Nedd4+/group had significantly higher percentage of alternation (36.0 ± 2.8% vs. 27.4 ± 1.8%,
P<0.01) than wild-type group (Figure 5.2), indicating better spatial working memory in
Nedd4+/- mice.
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Figure 5.1 Improved Fear-associated Memory in Nedd4-haploinsufficient Mice.
(A) Immediate freezing score during the first day training (n=23-46 per group). Time
intervals for the fear conditioning training on day 1. m1: minute 1, 0–60 s; m2: minute 2,
60–120 sec; m3: minute 3, 120–180 sec; tone 1: 180–200 sec; iti: inter-tone interval,
200–260 sec; tone 2: 260–280 sec; end: 280–340 sec. (B and C) Freezing score during
retrieval tone test (B) or contextual test (C) on day 2 (n=23-46 per group). Time intervals
for the tone retrieval test on day 2: pre-tone: 0–180 sec; tone: 180–200 sec. Time interval
for the context fear retrieval test on day 2: context: 60–180 sec. Data represent mean ±
SEM; **P<0.01; n.s., no significance.

58

Figure 5.2 Improved Learning and Memory in Cross Maze Test in Nedd4haploinsufficient Mice.
(A) Total number of arm entries in Nedd4+/- (Het) and wild-type (WT) mice (n=14-23 per
group). (B) Ratios of spontaneous alternation versus total entry number (n=14-23 per
group). Data represent mean ± SEM; *P<0.05, **P<0.01.
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5.2.3 Nedd4-haploinsufficient Mice Display Impaired Water Maze Performance
Fear conditioning and cross maze indicate different forms of memory (associative
and working), but both tests can sometimes be compromised by anxiety/depression. In
order to confirm phenotype of improved learning and memory in Nedd4+/- mice, we
performed a third behavioral test, the Morris water maze test, which has become the
"gold standard" for assessing hippocampus-dependent spatial learning and memory. To
our surprise, the Nedd4+/- mice displayed severely impaired learning and memory in
water maze task. While the latency in wild-type group started from ~36 s and dropped to
~12 s at the end of the training, the average latency in Nedd4+/- mice remained above 30
sec at day 10 (Figure 5.3A). In the probe test where the hidden platform was removed
and mice were allowed to swim in the pool freely for 60 s, unlike the wild-type mice that
spent most of the time swimming around the site of hidden platform, Nedd4+/- mice swam
across four platforms randomly (Figure 5.3B).These mice took much longer time in
finding the hidden platform, suggesting that they had impaired spatial learning and
memory abilities. Brain insulin signaling has been implicated in spatial memory
processing (Zhao et al., 1999). To examine the brain insulin signaling in Nedd4+/- mice,
we dissected cortical tissue from P0 mouse brain and stimulated the tissue with insulin.
Interestingly, we found that the insulin signaling in cortical tissue appeared to be
attenuated in Nedd4+/- mice in a dose- and time-dependent manner, especially within 15
min of insulin administration (Figure 5.4).
5.2.4 Nedd4-haploinsufficient Mice Display Anxiety-like Behavior
When testing the physical activity of Nedd4+/- mice in an open field test, we found
that although the total activity and distance traveled were not distinguishable between
Nedd4+/- and wild-type mice, Nedd4+/- mice spent significantly less time in the center of
the field (Figure 5.5), This indicates anxiety-like behavior as mice prefer to stay or travel
close to the side of the box. To confirm this observation, we tested these mice in a
light/dark box test, which is widely used in the assessment of anxiety. Interestingly,
Nedd4+/- mice made fewer transitions and tended to stay in the dark compartment,
suggesting higher anxiety levels in Nedd4+/- mice than controls (Figure 5.6).
5.3 Summary
In the current chapter, we studied the in vivo neuronal behavioral outcome using
Nedd4+/- mice. We found that the partial loss of NEDD4 function is sufficient to cause
several neurobehavioral alterations using different experimental paradigms, including
fear conditioning, cross maze, Morris water maze, open field and light/dark box test. The
seemingly paradoxical observations are that Nedd4+/- mice performed in opposing trends
in different behavioral paradigms. However, these behavioral tests index distinct working
memory. For example, the contextual fear conditioning is a form of fear-associated
memory which involved functions of amygdala and hippocampus. Although cross maze
and Morris water maze are both tests for assessing rodents’ working memory, they are
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Figure 5.3 Impaired Learning and Memory in Morris Water Maze Test in Nedd4haploinsufficient Mice.
Mice were 2 months old at the beginning of the test. The apparatus is a circular pool
filled with RT water made opaque with non-toxic paint. An escape platform was
submerged 0.5 cm below the surface of the water (up-right), to allow the mice to escape
from swimming. (A) Latency to find the target platform in the Morris water maze. Both
groups had identical swim speed as indicated in the visible section. Nedd4+/- (Het) mice
spent more time in finding the hidden platform compared to their littermate wild-type
(WT) mice from day 3 to day 10 (n=14-23 per group). (B) Representative pictures of
swim path in maze during probe trial. Data represent mean ± SEM; **P<0.01.
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Figure 5.4 Partial Loss of NEDD4 Reduces Insulin-stimulated IR
Autophosphorylation.
Dose-response and time-course studies of IRȕ phosphorylation levels in cortex in
littermate wild-type (WT) and Nedd4+/- (Het) P0 neonatal mice. (A) The cortical tissue
was incubated with different doses of insulin for 15 min. (B) The cortical tissue was
incubated with 1 μM insulin for indicated times. The bottom panels are protein
quantification results. Data represent three independent experiments. All data are mean ±
SEM; *P<0.05.
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Figure 5.5 Locomotor Activity Test Indicates Anxiety-like Behavior in Nedd4haploinsufficient Mice.
Mouse was placed in an open-field box, equipped with infrared beams that automatically
measures total locomotor activity by beam-breaks and with a camera on top that
measures the distance the mouse travelled. Mouse was allowed to explore freely in a 10min session. (A) Total number of beam breaks indicates total activity. (B) Total distance
traveled in inches. (C) Nedd4+/- (Het) mice spent less time in center than the wild-type
(WT) mice, indicating increased anxiety levels (ND n=14-23 per group, HFD n=8-10 per
group). Data represent mean ± SEM; *P<0.05.
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Figure 5.6 Light/dark Box Test Indicates Anxiety-like Behavior in Nedd4haploinsufficient Mice.
Anxiety responses are assessed in a chamber segregated into opaque (dark) and nonopaque (light) compartments. Camera recorded the movement of the mice between
compartments. (A) Nedd4+/- (Het) mice had less number of transitions between light and
dark compartments than the wild-type (WT) mice. (B) Het mice traveled shorter distance
in the light compartment than the WT mice. (C) Moving speeds were identical between
two groups. (D) Het mice spent less time in the light compartment. (E) Percentage of
time spent in light compartment was less in Het group. These data indicate that Het mice
have increased anxiety levels, as mice have a preference for darkness (n=14-23 per
group). Data represent mean ± SEM; *P<0.05, **P<0.01.
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different in that the prior one is for assessing the short-term memory, while the latter one
is for the long-term memory. In Chapter 3, we have shown that NEDD4 regulates insulin
signaling in peripheral insulin sensitive tissues under basal condition (ND feeding). Here,
we show that the insulin signaling in cerebral cortex in neonatal mice was also
diminished. The impaired long-term spatial working memory of Nedd4+/- mice might be a
result of their attenuated insulin signaling in the brain, as central insulin actions are
known to have modulatory roles in long-term memory consolidation (Dou et al., 2005).
This hypothesis awaits validation in future investigation.

65

CHAPTER 6.

DISCUSSION

NEDD4 is the prototypical protein in a family of E3 ligase which has a conserved
role in mediating ubiquitin-dependent endocytosis and/or degradation of plasma
membrane proteins. In Chapters 3 and 4, we reported that Nedd4+/- mice, despite being
moderately insulin resistant, were protected against diet-induced obesity and hepatic
steatosis. This provides the first evidence for the involvement of NEDD4 in metabolic
regulation. Further, we showed that NEDD4 regulates ȕ-adrenergic-mediated lipolytic
response in vivo and ex vivo. This is consistent to a previous in vitro study of NEDD4-ȕ2adrenergic receptor regulation by Shenoy et al. (Shenoy et al., 2008). In addition,
Nedd4+/- mice under obesogenic (HFD or aged) conditions were accompanied with
UHSUHVVHGH[SUHVVLRQRI33$5ȖLQZKLWH adipose tissue. NEDD4 interacted robustly with
33$5Ȗin vitro and in vivo by co-immunoprecipitation. Downregulation of NEDD4 by
shRNA-targeting strategy in 3T3-L1 preadipocytes impaired the adipogenic response,
UHVXOWLQJLQGHFUHDVHG33$5ȖSURWHLQOHYHOV Thus, our study has identified, for the first
time, a positive regulation between NEDD4 and PPARȖ in adipocytes. These findings are
significant since adipose tissue mass is directly related to the risk of progression from
insulin resistance to T2D (Magre et al., 2001). In Chapter 5, we provided preliminary
data on several neurobehavioral phenotypes of Nedd4+/- mice, including altered learning
and memory abilities and anxiety levels; we also found reduced insulin signaling in
cortical neurons in neonatal Nedd4+/- mice, indicating an integral role of NEDD4 in
maintaining normal neuronal insulin sensitivity and brain function. In summary, our
studies provide solid evidence for the involvement of NEDD4 in the regulation of both
peripheral metabolism and CNS functions. In this chapter, we attempt to place our studies
in context of other published work. We will also discuss the pitfalls of our experiments
and implication of the data for future studies.
6.1 Pathophysiological Roles of NEDD4 in Obesity
There are a variety of animal models used for obesity research. The most
commonly used are the following four categories: genetically derived (ob/ob mice, db/db
mice and Zucker rats), diet-induced (rodents fed a HFD containing 32-60% of calories
from fat), surgically (ventromedial hypothalamic-lesioned rodents) and chemically (gold
thioglucose-treated mice) induced obesity (Lutz and Woods, 2012). Here, we chose to
use a specific HFD containing 60% of calories from fat (mostly lard), which induces
rapid weight gain and fat accumulation in several strains of mice. One of these quick
responders is the C57BL/6J strain of mice. A HFD with 60% of fat can trigger weight
gain and glucose intolerance in C57BL/6J mice as early as 1 week and 8 weeks after
feeding, respectively (Lin et al., 2000). Obesity, T2D and metabolic syndrome are
multifactorial and polygenic in their origins. Therefore HFD feeding strategy is
advantageous over monogenically mutated rodent models. Nonetheless, HFDs with
various concentrations of fat induce different degrees of obesity in mice. The extreme
density of fat in diet (>60 kcal%) will result in greatest degree of obesity,which, however,
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is questioned by its physiological relevance (Buettner et al., 2007), as no human food
contains such high calories.
By feeding the Nedd4+/- and wild-type mice 60 kcal% fat HFD, and following the
body weight changes in these mice for 9 months, we observed that: HFD induced
significant weight gain in wild-type male mice after 1 week, while an obvious increase in
body weight in Nedd4+/- male mice was observed at 4 weeks after feeding; there was a
30% decline in the average weight gain in Nedd4+/- group of both genders at the end point
of the study, though the female mice gained weight more slowly than male mice. Body
weight difference between ND-fed Nedd4+/- and wild-type mice revealed significance
with two-tailed student's t test, but not with two-way ANOVA with Bonferroni posttest
correction when comparing between HFD and ND groups with both genotypes,
suggesting that when diet was considered as a factor in addition to genotype, body
weights between ND-fed Nedd4+/- and wild-type mice were not considered significantly
different.
6.1.1 The Energy Balance in Nedd4-haploinsufficient Mice
In humans, dairy fat through the gastrointestinal tract is transformed to
chylomicrons and lipoproteins, a portion of which is metabolized and utilized as energy
supply and the rest is stored in adipose tissue for long-term storage (Shi and Burn, 2004).
In light of the energy balance equation, obesity represents a form of energy surplus. It is
commonly believed to be a result of either increased energy intake and/or decreased
energy expenditure. The absolute calorie intake was reduced by 15% in Nedd4+/- male
mice and by 12% in Nedd4+/- females compared to their respective wild-type controls.
However, when adjusting daily calorie intake for per g body weight, we found no
significant difference between gender-matched Nedd4+/- and wild-type mice. Basal
phosphorylation levels of mTOR and AMPK in hypothalamus were similar between
genotypes. Direct intracerebroventricular (i.c.v.) injection of leptin into mice evoked
similar degree of increase in STAT3 phosphorylation in the two genotypes (see
Appendix). These data suggest unaltered energy intake in HFD-fed Nedd4+/- mice
compared to the wild-type controls. These data, however, do not rule out the possibility
of altered energy absorption rate by the intestinal tract in Nedd4+/- mice on HFD, which
requires taking the energy remnant in urine and feces into consideration.
The body's thermogenesis at rest (basal metabolic rate) comprises a large
proportion (60-70%) of energy expenditure. However, accurate measurement of the basal
metabolic rate in mouse present a challenge, as the animals are small and their physical
activities are impacted by environmental changes. In addition accurate analysis of the
energy expenditure data versus body size is difficult, because it requires advanced
equipment (Speakman, 2013). Nevertheless, alteration of basal metabolic rate is normally
associated with changes in metabolism in BAT or skeletal muscle, which can be indexed
by the expression of thermogenic genes and tissue mass. According to our analysis, the
ratios of BAT and skeletal muscle weight to body weight were similar between genotypes
with or without HFD feeding. Thermogenesis-related gene expression in BAT and
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expression of UCP1 in BAT, WAT or skeletal muscle were also unchanged by NEDD4
downregulation. Moreover, physical activity as measured in afternoon by open-field test
did not show any difference. These data suggest that the energy expenditure may be
unaffected in the HFD-fed Nedd4+/- mice. Again, these data do not rule out a possible
contribution of thermogenesis, as there might be activity change in Nedd4+/- mice during
other untested time spectrum, considering the fact that mice are nocturnal animals.
A third component in energy balance is the efficiency of energy storage. In times
of positive energy balance, adipose tissue expands through adipogenesis and lipogenesis
to store excess energy in the form of triglycerides, serving as a body defense against the
overexposure of excessive lipid; in times of negative energy balance, adipose tissue is
mobilized through the lipolysis process to release FFAs, which can be oxidized by other
organs as fuel. We hypothesizes that the adipogenesis, lipogenesis, and/or the lipolysis
pathways are altered in Nedd4+/- mice on HFD. Indeed, our data imply that the pathways
of lipolysis and adipogenesis may contribute to the "lean" phenotype of HFD-fed
Nedd4+/- mice. By performing in vivo and ex vivo lipolysis assays, we confirmed that at
least the lipolytic action was increased in HFD-fed Nedd4+/- mice. In addition, knocking
down NEDD4 in 3T3-L1 preadipocytes inhibited its conversion to mature adipocytes; we
also observed an associated reduction of PPARȖ expression levels in WAT in these mice,
which implies that the adipogenesis process may be affected as PPARȖ is the central
adipogenic transcriptional factor.Besides adipogenesis and lipolysis, the de novo
lipogenesis (DNL) is another important contributor to fat accumulation. DNL pathway
can be activated by HFD and can take place in both liver and adipose tissue (Strable and
Ntambi, 2010). In our studies, Nedd4+/- mice were protected against HFD-induced liver
steatosis, raising the possibility of decreased DNL in liver and/or adipose tissue. Indeed,
the yeast homologue of NEDD4, Rsp5p, has been demonstrated to regulate unsaturated
fatty acid synthesis (Hoppe et al., 2000). In Hoppe et al.'s study, they investigated the
physiological outcomes in yeast cells harboring mutant Rsp5, and found that Rsp5 is a
vital factor for the survival of yeast cells. To identify target genes for Rsp5, they screened
strains carrying yeast library cDNAs to identify strains that could restore the toxic effects
of Rsp5 deletion. Finally, the OLE1 gene which encodes stearoyl CoA desaturase (SCD,
also called9 fatty acid desaturase) was confirmed as a target gene of Rsp5 by
ubiquitinating and activating the yeast transcription factors SPT23 and MGA2
(homologous to mammalian NF-ț%). In mammals, SCD controls the synthesis of oleic
acid, a form of monounsaturated fatty acids with important physiological functions.
Intriguingly, depletion of SCD-1 protected mice against obesity and liver steatosis
(Cohen et al., 2002; Ntambi et al., 2002), coincidently reminiscent of the Nedd4+/- mice
phenotypes. Thus, it is of particular interest to investigate the effect of NEDD4 on
lipogenic pathways. Particularly, it is interesting to see whether the effect of Nedd4
haploinsuffciency on obesity is mediated through SCD, or through its interplay with
PPARȖ and other lipogenic and adipogenic factors.
Using an obesity model induced by HFD, we demonstrate that NEDD4 is a
modulator of lipid accumulation and is a novel regulator of adiposity in mice. Of note,
drastic differences in weight gain between the two genotypes were only observed in
HFD-fed group. Although we also observed a trend for decreasing body weight with
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aged-obese Nedd4+/- mice, the data failed to display statistical significance, presumably
due to small cohort size and great individual variation.
6.1.2 Peripheral Insulin Sensitivity in Nedd4-haploinsufficient Mice
Cao et al. reported reduced insulin signaling in NEDD4 knockout MEFs.
Similarly, we also observed decreased insulin sensitivity in Nedd4+/- mice at postnatal
stage during ITT. Insulin signaling in several insulin-responsive organs of Nedd4+/- mice
was also impaired. However, we did not observe significantly increased expression of
either Grb10, as reported by Cao et al., or PTEN, a previously identified NEDD4
substrate in cancer and neuronal cells (Kwak et al., 2010; Wang et al., 2007), suggesting
cell-type-dependent substrate specificity for NEDD4. Despite the insulin tolerance defect,
ND-fed Nedd4+/- mice were paradoxically glucose tolerant with normal basal blood
glucose level. Collectively, the data suggest that ND-fed Nedd4+/- mice possess only
mildly decreased insulin sensitivity, which may be compensated by increased insulin
secretion through mild ȕ cell hypertrophy and/or hyperplasia. Surprisingly, chronically
HFD-fed Nedd4+/- mice displayed the same degree of glucose intolerance despite lower
circulating insulin levels, compared to HFD-fed controls. This dissociation of insulin
resistance from body fat was observed in other murine models —such as the PPARȖ2
knockout (Medina-Gomez et al., 2007; Medina-Gomez et al., 2005; Zhang et al.,
2004),the Txnip knockout (Chutkow et al., 2010), the Pref-1 overexpressing (Lee et al.,
2003), and the adiponectin overexpressing (Kim et al., 2007)—which is similar to the
phenotypes of 33$5ȖDJRQLVW treatment (Lehrke and Lazar, 2005). The adiponectin
transgenic mice on the ob/ob background exhibited expanded adiposity, which was,
surprisingly, associated with improved metabolic outcomes, such as increased insulin
sensitivity and glucose tolerance (Kim et al., 2007). While in the case of PPARȖ2
knockout and Pref-1 overexpressing mice, adipose mass was profoundly reduced, yet was
associated with several metabolic abnormalities including insulin resistance. In contrast
to the adipocentric view which considers the excessive fat storage as the main cause of
insulin resistance and T2D (Cederberg and Enerback, 2003), these evidence suggest that
the fat volume unlikely contributed directly to the obesity-associated insulin resistance.
Rather, the expandability of adipose tissue and the ectopic lipotoxicity may be the
primary factors linking obesity and insulin resistance (Virtue and Vidal-Puig, 2010).
An unexpected finding from our work is that although Nedd4+/- mice on ND were
resistant to insulin-mediated glucose clearance effect during ITT, GTT by i.p. glucose
injection did not reveal difference between the two genotypes. This observation of
impaired insulin tolerance yet normal glucose tolerance is coincidently similar to the
phenotypes of PPARȖ2 knockout mice, suggesting that NEDD4 and PPARȖ2 might
regulate overlapping molecular pathways in the control of insulin sensitivity(Zhang et al.,
2004). Furthermore, in a state of energy surplus evoked by HFD, Nedd4+/- mice were,
paradoxically, protected against obesity, yet did not become more insulin resistant. In
contrast to the deleterious effects on insulin sensitivity by 16 weeks of HFD seen in wildtype mice, insulin sensitivity in Nedd4+/- mice as assessed by ITT did not further
deteriorate.These phenotypes are, again, reminiscent of the phenotypes of PPARȖ+/- mice;
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these mice were protected against obesity an insulin resistance induced by HFD (Kubota
et al., 1999). Our Western-blot analysis of PPARȖ protein levels in adipose tissue from
Nedd4+/- and wild-type mice under HFD-fed or aged conditions revealed a positive
correlation between NEDD4 and PPARȖ levels, though the changes in PPARȖ expression
levels under aged condition failed to achieve statistical significance. The levels of
NEDD4 were better correlated with PPARȖ2 than with PPARȖ1 under HFD-fed
condition, but were correlated similarly with both isoforms under aged condition. These
results imply that NEDD4 may be an upstream regulator of PPARȖ, and that the
metabolic effects of NEDD4 may be mediated through PPARȖ, especially PPARȖ2.
In terms of the discrepancy that the "insulin resistant predisposed"Nedd4+/- mice
did not become more insulin resistant, as is also the case with PPARȖ+/- mice, one
possible explanation might be that these mice already had reduced insulin sensitivity on a
ND; the molecular mechanisms through which their partial deficiency leads to insulin
resistance on the ND are very similar to the mechanisms underlying insulin resistance
induced by a HFD, and therefore insulin resistance did not become further impaired
(Medina-Gomez et al., 2005). Another possibility is that reduced adiposity in HFD-fed
these mice could result in a modest improvement in insulin sensitivity, which might
compensate the additive effect of haploinsufficiency on HFD-induced insulin resistance.
Mechanisms underlying these phenotypes thus far only partially understood. Deeper
understanding of the regulation, signaling, and tissue-specific roles of NEDD4 could
provide novel mechanistic insights and new therapeutic targets for its actions related to
obesity and insulin resistance.
6.1.3 Regulation of Lipolysis by NEDD4
A study conducted by Langin et al. showed that obesity is associated with
resistance to catecholamine-induced lipolysis (Langin et al., 2005), suggesting that
enhancing lipolytic rate is a potential strategy to remove fat and treat obesity. Although
there is a widespread acceptance of the notion that an increase in lipolysis would result in
facilitated release of FFAs into bloodstream, thereby mediating several adverse metabolic
effects, including insulin resistance (Nielsen et al., 2004). This idea is now being
challenged by recent studies. Clinically, even severe insulin resistance, can coexist with
obesity with no alteration in FFA levels. On the other hand, increased levels of FFAs are
not necessarily associated with insulin resistance (Karpe et al., 2011), suggesting that the
increased levels of plasma FFA associated with obesity is a consequence rather than a
cause (Byrne et al., 1999). Furthermore, enhanced lipolysis does not change serum FFAs
levels, as demonstrated in several murine models(Ahmadian et al., 2009; Ahmadian et al.,
2010; Jaworski et al., 2009; Saha et al., 2004; Tansey et al., 2001). Therefore, promoting
fat loss by enhancing lipolysis may still be an intriguing strategy for the treatment of
obesity.
In human, catecholamines mainly epinephrine and norepinephrine are the
hormones with pronounced lipolytic action via the seven transmembrane protein ȕ-AR.
7KUHHGLVWLQFWȕ-AR subtypes have been identified including —ȕ1-$5ȕ2-AR and ȕ3-AR.
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The ȕ-AR-mediated lipolytic process in adipose has been extensively studied in human
and rodent adipocytes. However, the human and rodent adipocytes have differential
responsiveness to ȕ3-AR agonists to activate the lipolysis pathway. Human adipocytes
respond much less efficiently to the ȕ3-AR agonist. Functional assays by applying ȕagonists indicate that catecholamines primarily activate ȕ1-AR and ȕ2-AR, rather than the
ȕ3-AR in both white and brown adipocytes from rats (Bahouth and Malbon, 1988;
Galitzky et al., 1995). Although the ȕ3-AR is the only ȕ-AR specifically expressed in fat,
RT-PCR results from a previous report suggest that ȕ1-AR and ȕ2-AR are the major
subtypes in the subcutaneous adipose tissue from rat (McNeel and Mersmann, 1999),
consistent with the functional assays. Our studies show that isoproterenol-stimulated
lipolytic response in Nedd4+/- mice on HFD is remarkably higher than that from their
wild-type littermates on HFD. Since the ȕ3-AR subtype does not significantly contribute
to isoprenaline-induced lipolysis (Tavernier et al., 1996). We thereby speculate that the
effect is primarily through ȕ1- or ȕ2-AR.
The ȕ-AR belongs to a G protein coupled receptor (GPCR) family. Sustained
DFWLYDWLRQRIWKHȕ-ARs leads to receptor desensitization and/or degradation. While the
ȕ1-AR is believed to be resistant to agonist-induced ubiquitination and degradation
(Liang and Fishman, 2004), the E3 ligase-mediated ubiquitination of ȕ2-AR plays an
important role in regulating the abundance of the receptor. NEDD4 is known to be
recruited to the agonist-DFWLYDWHGȕ2-$5YLDWZRDGDSWRUSURWHLQVȕ-arrestin 2 and
arrestin-domain-containing proteins (ARRDCs), especially ARRDC2-4 (Han et al.,
2013b; Nabhan et al., 2010; Shenoy et al., 2008). Shenoy et al. demonstrated that MDM2
mediates ubiquitination of ȕ2-AR and their adaptor protein ȕ-arrestin 2 which regulates
the initial step of receptor endocytosis (Shenoy et al., 2001), and NEDD4 mediates
subsequent receptor ubiquitination which targets receptors for lysosomal degradation
(Shenoy et al., 2008). Although discrepant results from Nabhan et al. suggest that
ARRDC3, rather than ȕ-arrestin 2, serves as the adaptor protein (Nabhan et al., 2010),
both studies are not mutually exclusive in that they unequivocally delineate the role of
NEDD4 in downregulating ȕ2-AR. Later, Han et al. demonstrated that the ȕ-arrestin 2 is
the first adaptor protein between NEDD4 and ȕ2-AR to facilitate clathrin-dependent
internalization, while the ARRDCs serve as the secondary adaptors lead the NEDD4 and
ȕ2-AR complex to the early endosome (Han et al., 2013b). Interestingly, ARRDC3GHILFLHQWPLFHDOVRGLVSOD\SDUWLDOUHVLVWDQFHWRREHVLW\YLDPRGXODWLQJȕ-adrenergic
signaling (Patwari et al., 2011). In spite of the fact that NEDD4 has a substantial number
of substrates, very few in vivo studies have been reported to validate its
pathophysiological relevance. It should be stressed that our work, for the first time,
demonstrates a physiological role of NEDD4-PHGLDWHGȕ2-AR signaling in the context of
lipolysis.
Even though agonist-stimulated lipolysis was higher in the HFD-fed Nedd4+/mice, circulating lipid concentrations did not increase. This is consistent with phenotypes
reported in adipose ATGL transgenic mice (Ahmadian et al., 2009), adipocyte
phospholipase A(2) (AdPLA) knockout mice (Jaworski et al., 2009), perilipin knockout
mice (Saha et al., 2004; Tansey et al., 2001). In these mice, the serum FFAs levels were
not altered, even though they all exhibited enhanced lipolysis. Reduced adipose mass
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could have resulted in lower basal FFA release, which might have compensated for the
elevated lipolysis in the HFD-fed Nedd4+/- mice. $OWHUQDWLYHO\LQFUHDVHGȕ-oxidation at
ectopic sites could have maintained the circulating lipid homeostasis, although in the
current study, we do not have evidence to support this hypothesis. In agreement with our
speculation, the murine models mentioned above all exhibited enhanced ȕ-oxidation at
least in adipose tissue (Ahmadian et al., 2009; Jaworski et al., 2009; Saha et al., 2004).
One discrepancy from these studies is that, we only observed enhanced lipolysis in HFDfed Nedd4+/- mice under the stimulation ȕ-agonists, while the basal lipolysis appears to be
unaffected, which implies that the altered lipolysis in these mice is ligand dependent.
This may also explain the discrepancy that the lipolytic response was only affected in the
HFD-fed or aged animals, as chronic dietary fat or aging could act as a stressor that
stimulates sympathetic nerve activity, releasing catecholamines which facilitates energy
expenditure priPDULO\WKURXJKWKHUPRJHQHVLVDQGȕ-AR mediated lipolysis (Lowell and
Bachman, 2003).
6.1.4 Regulation of Adipogenesis by NEDD4
Chronic adipose tissue remodeling represents a fundamental and highly
coordinated process involving the participation of different cell types, including
endothelial precursors, immune cells, and preadipocytes (Sun et al., 2011). In mice at an
earlier stage of obesity (within the 16-week design of HFD feeding), adipose tissue
expands primarily through hypertrophy. At later stages (after 16 weeks of HFD feeding),
a high degree of adipocyte apoptosis (approximately 80%) becomes evident, so that
adipose expansion relies on hyperplasia (Strissel et al., 2007).
Adipogenesis contributes to the expansion of adipose tissue; therefore,
pharmacological intervention to inhibit adipogenesis appears to be a logically promising
approach to restrain obesity. However, factors that impede adipocyte growth and
expansion also lead to metabolic defects (Stephens, 2012). For example, Pref-1 is a
negative regulator of adipogenesis secreted by preadipocytes; Pref-1 transgenic mice are
insulin resistant despite its resistance to HFDIO (Villena et al., 2008). Another example is
PPARȖ2 knockout mice, which also display insulin resistance (Medina-Gomez et al.,
2007); PPARȖ2 is generally believed to be more effective in pro-adipogenesis than
PPARȖ1. Hence, factors that limit adipose expansion without altering insulin sensitivity
should receive more attention since they represent a promising strategy for weight loss.
Although our work has revealed that NEDD4 and 33$5Ȗ expressions are
positively correlated and that these two proteins can be co-immunoprecipitated, future
studies must consider the following key questions. Are the NEDD4 and PPARȖ
physically interacted, or through an adaptor? Does the NEDD4-33$5ȖLQWHUDFWLRQ
account for NEDD4’s UHJXODWLRQRI33$5ȖH[SUHVVLRQ"Where does the interaction occur?
What is the physiologic consequence of attenuating the NEDD4-33$5ȖLQWHUDFWLRQ
during adipocyte differentiation? During our investigation, a study from Han et al.
reported the physical interaction between PPARȖ and NEDD4 through PPxY motif in an
overexpression in vitro system. They claimed that NEDD4 is the (OLJDVHIRU33$5Ȗ in
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response to the ȕ-estradiol treatment in HeLa cells (Han et al., 2013a). However, in our
study, we did not see a significant reduction in PPARȖ levels by NEDD4 overexpression,
suggesting that PPARȖ is subjected to the regulation of different E3 ligases under
different conditions. In the current study, we observed in vitro that knockdown of
NEDD4 in 3T3-/SUHDGLSRF\WHVUHGXFHG33$5ȖSURWHLQH[SUHVVLRQDQGLQKLELWHG
adipogenesis. We propose that 1(''LQWHUDFWVDQGVWDELOL]HV33$5Ȗ in preadipocytes
when PPARȖlevel is low, prohibiting its degradation by other E3 ligases, whereas
1(''GLVDVVRFLDWHVIURP33$5Ȗ and releases it for nuclear translocation and
transactivation (Hauser et al., 2000) during the adipocyte differentiation process (Figure
6.1). Due to the high lipid content of adipose cells, it is technically difficult to study
33$5ȖORFDOL]DWLRQDQGWUDIILFNLQJin vivo. Using the 3T3-L1 preadipocytes, Thuillier et
al. VKRZHGWKDW33$5ȖGLVWULEXWHVevenly in the cytosol and nucleus of the preadipocyte;
ZKHUHDVGXULQJGLIIHUHQWLDWLRQ33$5ȖLQFUHDVHVLQWKHF\WRVROZKLOHUHPDLQLQJFRQVWDQW
within the nucleus (Thuillier et al., 1998). Localization of NEDD4 in adipocytes has not
been reported, but NEDD4 localizes to both cytoplasm and nucleus in most cell types.
7KH1(''33$5ȖFRPSOH[SUREDEO\GHULYHVIURPWKLVRYHUODSSLQJSURWHLQSRRO6LQFH
NEDD4’s effects on lipolysis and adipogenesis can be reproduced in vitro (at least in
3T3-L1 cells), these observations are unlikely to be secondary consequences from other
organs, such as muscle and liver. Tissue-specific signaling and function of NEDD4 are
worthy for further investigation using conditional knockout mice.
6.1.5 E3 Ligases in Metabolism
E3 ligase is the final step for the conjugation of ubiquitin to substrates managing
the selection of targets, and therefore has been substantially studied in diseases with
abnormal protein accumulation, such as neurodegeneration and cancer (Ardley and
Robinson, 2004; Sun, 2003). There has been very limited investigation of this class of
enzymes for the metabolic functions. Rsp5p, the most well-studied yeast E3 ligase,
participates in the process of unsaturated fatty acid synthesis (Hoppe et al., 2000). Its
mammalian homologues—NEDD4 and ITCH (also called AIP4)üare two structurally
related E3 ligases belonging to the nine-member HECT NEDD4 family. NEDD4 and
ITCH both recognize the proline-rich consensus sequence motifs (e.g., PPxY and PPLP)
and thereby ubiquitinate several overlapping targets in vitro (Bray, 2006), including the
RING-type E3ligase Cbl-b (Magnifico et al., 2003). Comparative study of immunity
using genetically modified mice indicates that NEDD4 and ITCH regulate distinct
pathways in vivo (Yang et al., 2008). Recently, depletion of ITCH in mice has been found
to reverse HFD-induced obesity and its related metabolic disorders, as well as an aberrant
M2 macrophage polarization (Marino et al., 2014). Our work shows that NEDD4 partial
depletion also attenuates HFDIO progression and pro-inflammatory response, likely
through decreased M1 macrophage recruitment. These findings suggest that distinct
metabolic and inflammatory pathways regulated by NEDD4 and ITCH may converge to
produce an anti-obese action. The NEDD4/ITCH and Cbl-b were frequently found to be
mutually impeded in previous studies (Guo et al., 2012; Thien and Langdon, 2005).
Coincidentally, Cbl-b depletion caused aggravated HFD-induced insulin resistance and
macrophage recruitment (Abe et al., 2013; Abe et al., 2014), consistent with its inverse
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Figure 6.1 Schematic Diagram of NEDD4 Regulation of Lipolysis and Adipogenesis.
Under pathological conditions such as aging or HFD-induced obesity, plasma levels of
catecholamine and FFA increase. The increased presence of catecholamine promotes
ligand-induced endocytosis and degradation of ȕ2-AR mediated by NEDD4, resulting in
fewer receptors on the surface of adipocyte and reduced lipolysis. On the other side,
elevated FFA uptake into adipocyte provides more ligands for PPARȖ. NEDD4 interacts
DQGVWDELOL]HV33$5Ȗprohibiting its degradation by other E3 ligases and facilitates
adipogenesis mediated through PPARȖ and RXR as heterodimer. Although detailed
regulation of this process by NEDD4 await further investigation.
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relationship to NEDD4/ITCH. The crosstalk of molecular pathways among these three E3
ligases in obesity is still waiting to be further investigated.
6.2 Physiological Role of NEDD4 in CNS
6.2.1 Nedd4 Haploinsufficiency Leads to Altered Cognitive and Anxiety-like
Behaviors
In our studies, adult Nedd4+/- mice showed significant impairment in behavioral
by the water maze test. Overall tissue pathological alteration was not observed.
Previously, Nedd4+/- mice were reported to have deficits in the development of cardiac
and neuromuscular junction (Fouladkou et al., 2010; Liu et al., 2009). This raises the
question that if the impaired water maze performance in Nedd4+/- mice might be
unrelated to their cognitive functions. In our current study, physiological parameters,
such as organ weights, in Nedd4+/- mice were similar to those of wild-type counterparts.
During the visible platform training, Nedd4+/- mice performed well but only displayed
impairment in the hidden section. This pattern of behavior indicates that the Nedd4+/mice does not have visual problems and suggest a cognitive deficit. These findings
implicate NEDD4 in certain unidentified processes underlying neuritic plasticity in the
mammalian brain, involving the hippocampal formation. This is the first physiological
evidence of NEDD4 in potential regulation of learning and memory.
As Nedd4+/- mice performed differently in cross maze, fear conditioning and
water maze, we are unable to conclude so far whether this discrepancy is a result of the
different settings in experimental paradigms or indicates a differential regulation of shortterm and long-term memory by endogenous NEDD4. Future studies may need to include
more behavioral tests to assess their learning and memory ability in different
environments. In the current study, we also demonstrated that NEDD4 is involved in the
development of anxiety-like behaviors as judged by open-field and light/dark box tests.
The mechanisms underlying these neurobehavioral changes remain unknown. It should
be pointed out that water maze test is well known to cause severe anxiety on mice; mice,
compared to rats, have intrinsic fear of water. Therefore, in this case, water maze may
not be a suitable test for long-term memory. Instead, a dryland version called Barnes
maze test should be used to clarify whether Nedd4+/- mice indeed have impaired longterm memory.
6.2.2 Central Insulin Signaling in Nedd4–haploinsufficient Mice
Insulin and IR signaling are known to play critical roles in the process of learning
and memory (Zhao and Alkon, 2001; Zhao et al., 2004), however, examination of insulin
sensitivity locally in the hippocampus, especially in the adults, presents a challenge.
Because brain is extremely sensitive to hypoxia; death of neurons is prominent even
immediately following the isolation of the brain. To test the central insulin signaling in
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Nedd4+/- mice, we tried to administer insulin through i.p., intravenous (i.v.), and i.c.v.
routes. None of these methods provided reasonably accurate measurements. Due to the
existence of blood brain barrier, large molecules like insulin cannot be efficiently
delivered to the brain through i.p. or i.v. injection, since its transport requires a saturable
transporter (Banks et al., 1997). The concentration of insulin in the brain is, therefore,
largely dependent upon the transport efficiency. Insulin signaling is an acute effect which
can trigger phosphorylation events within 5 min of exposure to insulin. Furthermore,
hippocampus is less sensitive to insulin than regions like hypothalamus. Therefore, i.p. or
i.v. injections of insulin only induced a very mild degree of phosphorylation in IR in
hippocampus; also, a large variation between individual mouse was shown which is
likely due to the different transport efficiency of insulin in each mouse.
I.c.v. injection allows insulin to merge locally to the cerebrospinal fluid within
cerebral lateral ventricle and circulate to hippocampus. We did see a robust induction of
IR phosphorylation with i.c.v. injection. However, the data were difficult to interpret as
we saw increased IR phosphorylation levels in Nedd4+/- mice, which are opposite to the
peripheral insulin signaling data. We suspect that the ketamine/xylazine which we used to
anesthetize the mice before surgery may have compromised our data, as ketamine and
xylazine have been implicated in the regulation of insulin sensitivity (Heim et al., 2002;
Xiao et al., 2013). In the present study, we stimulated the cortical tissue isolated from P0
mice with insulin. Use of cortical tissue from neonatal mice has the advantage of being
relatively resistant to hypoxia therefore the isolated tissue not need for oxygen
supplement within the first 2 hours to maintain the viability of neurons. Shortcomings are
that the response only represents neonatal mice but not adult mice and that it is difficult
to study region-specific effects.
6.3 Future Studies
As discussed previously, to better solve mechanistic puzzle of tissue-specific
regulation by NEDD4 in adipocyte, a conditional knockout of NEDD4 in adipose tissue
can be considered. This will help circumvent the potential problems from CNS controls,
as the WAT is innervated by the sympathetic nervous system (SNS). Bioinformatics tools
including next generation RNA sequencing and proteomics may be employed to further
delineate cell-type specific substrates of NEDD4 in adipocytes.
To improve data quality, the metabolic cages could be considered for measurement
of basal metabolic rate and energy intake where the energy remnant in the urine and feces
can be carefully subtracted; a Dual-energy X-ray absorptiometry technique could be
utilized to measure lean/fat mass ratios and the hyperinsulinemic-euglycemic clamp
technique may be employed to assess insulin sensitivity. In addition, lentivirus has been
reported to have better infection rate than AAV for 3T3-L1 cells and therefore, may
improve the knockdown efficiency of NEDD4 and produce more significant results.
Alternatively, inducing adipogenesis using NEDD4 knockout MEF cells may be
considered. However, it should be noted that the differentiation efficiency in primary
MEFs varies from 10-70% and immortalized MEF cells normally require the
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overexpression of a pro-adipogenic transcription factor such as PPARȖ or C/EBPĮ
(Rosen and MacDougald, 2006). Future experiments could be designed to analyze the
interaction sites between NEDD4 and PPARȖ and clarify the physiological relevance of
their interaction. It would be of particular interest to see the metabolic outcome in mice or
adipocytes with the expression of PPARȖ lacking the binding sequences for NEDD4.
The Nedd4+/- mice are partially protected against HFD-induced obesity, implying
that NEDD4 may mediate the development of obesity to some extent. Surprisingly, the
several metabolically active tissues (hypothalamus, skeletal muscle and WAT) from
HFD-fed mice is not associated with aberrant NEDD4 protein expression. We speculate
that NEDD4 may be altered in a specific cell type (e.g. the preadipocytes). If so,
measuring the expression of NEDD4 in tissues with mixed cell types may yield false
information. Another plausible explanation is that NEDD4's activity is changed rather
than its expression levels. NEDD4 protein contains multiple catalytic cysteine residues
which are vulnerable to oxidative stress normally associated with obesity.
To confirm the behavioral phenotypes of Nedd4+/- mice, additional behavioral
tests such as Barnes maze, Y maze, and novel object recognition tests for spatial learning
and memory may be considered. Moreover, elevated plus maze and novelty-suppressed
feeding test may be performed to validate the anxiety-like behavior in Nedd4+/- mice.
Single-cell RNA sequencing and proteomics which avoid glial cell contamination may be
considered for further delineation of NEDD4 substrates in neurons. Future investigation
of insulin signaling in adult brain may consider using acute hippocampal slice preparation
following tissue slice electrophysiology experiments. This technique circumvents
contamination from anesthetics and reduces animal use, as both dose- and time-response
studies can be performed in slices from a single mouse.
6.4 Using Heterozygous Mouse as Models—Advantages vs. Disadvantages
Over the past two decades, genetically modified mice have provided us with
tremendous advantages in studying physiological functions of molecules in vivo (in
mammals), more specifically by manipulating their gene expression. Currently,
conditional knockout and transgenic technologies enable researchers to specifically delete
or overexpress certain genes at particular stages of life. In addition, it allows researchers
to do so in a tissue-specific or cell-type specific manner. These available technologies
greatly advance our understanding of the patho-physiological roles of a certain molecule
or molecular pathway in areas and at times of interest. However, limitations of this
technique remain with respect to controlling the expression level of a transgene, which
are so called dosage-dependent effects. Therefore, caution should be taken when
interpreting mouse phenotypes. For example, when knocking out a certain gene resulting
in morbidity or mortality, it is not implicit that its overexpression will necessarily lead to
beneficial effects. Often, to study a gene’s expected function by complete knockout or
overexpression may be compromised by embryonic lethality as in the case of Nedd4-/mice. The embryonic lethality indicates the crucial role of NEDD4 in IGF-1 signaling of
the early developmental stages, while overexpression of NEDD4, as in the case of
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neurodegeneration, leads to impaired IGF-1 signaling due to its role as the E3 ligase of
IGF-1R. Ultimately knockout and overexpression approaches are often used to study
physiological and pathological functions of a molecule, respectively. Expressing a
transgene at “right dosages” is of particular importance especially in disease-related
research.
Because it is uncommon for human molecules to be completely knocked out or
overexpressed, a more practical approach for study entails heterozygosity. In our studies,
we used a Nedd4 heterozygous mouse model to characterize the role of the Nedd4 gene in
metabolism and CNS functions. Though partial depletion of Nedd4 was sufficient to
produce a certain degree of metabolic phenotypes, the phenotypes observed were
generally mild. For example, Nedd4+/- mice exhibited moderate insulin resistance,
because their glucose clearance responded less efficiently to insulin during ITT.
Additionally, they had slightly higher serum insulin levels when compared to their wildtype littermates. Nedd4+/- mice were only partially resistant to HFD-induced obesity (30%
reduction in weight gain) without improvement in obesity-associated insulin resistance,
hyperglycemia, and hyperlipidemLD7KHH[WHQWRI33$5ȖGRZQUHJXODWLRQZDVDWPRVW
50%. Although using a diet with a lower percentage of calories from fat may help enlarge
the difference, whether these phenotypes or results can become more dramatic or
significant when Nedd4 is completely depleted is unknown. We believe that WAT is the
most selectively affected tissue under obesogenic conditions as demonstrated by our ex
vivo and in vitro data. Using heterozygous mice for an initial characterization offers
insight to the potential pathways affected. Further studies using tissue-specific
conditional knockout mice will be necessary to fully validate our hypotheses, which may
further advance our knowledge of the biological functions of NEDD4 in metabolism.
One should bear in mind the potential artifacts of the observed phenotypes
displayed through a genetically manipulated mouse model. The specificity of knockout or
knockdown effects in gene-trap studies has been questioned, because these mice are
hybrid in origin with both B6 and 129 type alleles. The 129-type alleles could also
contributes to the changes in phenotypes (Muller, 1999). The mutant mice in our present
study were heterozygous for not only the Nedd4 locus, but also the flanking region (B6 ×
129). It has been reported that the C57BL/6J (B6) mouse strain was more prone to
obesity, while the 129Sv strain was both obesity- and diabetes-resistant. Accordingly,
their intercross (B6 × 129) F2 mice were more obese-prone than 129 mice (Almind and
Kahn, 2004). In terms of neurobehavior, F1 hybrids of B6 and 129 strains perform better
than both inbred B6 and 129 strains in learning and memory tasks (Crawley et al., 1997).
Therefore, the resistance to diet-induced obesity and the behavioral deficits observed in
the Nedd4+/-mice of B6 × 129 hybrid origin are not likely explained by the contribution of
129-type alleles.
6.5 E3 Ligase as Drug Target
Dysregulation of UPS is associated with a number of hard-to-treat diseases,
including cancer, neurodegeneration, viral infection, muscle atrophy, and diabetes and
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inflammation. The reversible proteasome inhibitor bortezomib (Velcade®) was the first
FDA approved drug for the treatment of both multiple myeloma and mantle cell
lymphoma (Adams and Kauffman, 2004). The following year, the Nobel Prize in
Chemistry was awarded to jointly to Aaron Ciechanover, Avram Hershko, and Irwin
Rose for their discovery of UPS pathway (The official website of the Nobel Prize). In the
past decade, UPS-pathway-targeting compounds against more precise targets have
emerged as novel candidates for drug discovery. Considering the fact that humans
possess two E1 enzymes, ~30 E2 enzymes and several hundreds of E3 ligases,
compounds that target E1, or E2 enzymes are hopeless due to lack of specificity, and
thereby could result in undesirable side-effects. E3 ligases control the specificity of
substrate ubiquitination, making this class of enzymes the most appealing targets for drug
development. However, the E3 ligase targeting drug discovery process is still in its
infancy due to the complexity of UPS regulations (Wilkie et al. 2012). Our studies
provide experimental evidence for the involvement of NEDD4 E3 ligase in several
biological processes (lipolysis, adipogenesis, insulin signaling, learning/memory, and
anxiety), which may facilitate our understanding of complex E3-ligases-mediated UPS
regulation in the context of physiological and pathological settings. Full investigation of
each pathway in greater details at molecular levels will be instrumental to future
validation of NEDD4 as a suitable drug target.
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APPENDIX: SUPPLEMENTAL INFORMATION
For i.c.v. injection of leptin, anesthetized mouse was placed on a stereotaxic frame
paded with a heating pad set at 37 °C. The head of mouse was fixed on a palate suppor by
the ear bars. A small incision was made through the midline of the scalp to expose the
bregma and lamda. The angle of head was ajusted to ensure that the bregma and lamda
were in the same horizonal level. The skull was then punctured at a desired localization
with a mini drill. A 10 ȝl Hamilton syringe was loaded with leptin and inserted into the
lateral ventricle of the brain for the injection (stereotaxic parameters: -0.7ௗmm anteriorSRVWHULRUௗPPPHGLDO-lateral, and -1.9ௗmm dorsal-ventral). A total volume of 2 ȝl of
leptin (5 ȝg/ȝl) was injected slowly throught via syringe in 5 min. The syringe was left
untouched for an additional 5 min after the injection, and then slowly pulled away. After
30 min, mouse was euthanized; hypothalamus was isolated and snap-frozen until use.
Tissue lysates were subjected to Western-blot analysis (Figure A.1).
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Figure A.1 AMPK, mTOR, and Leptin Signaling in Hypothalamus of Nedd4haploinsuffcient Mice.
(A) Phosphorylation levels of STAT3 by leptin stimulation in the hypothalamus and
hippocampus (n=4).(C) Phosphorylation levels of mTOR (Ser2448) and AMPK (Thr172)
in hypothalamus in ND-fed mice between 12-16 weeks (n=3). (B) Quantification bar for
A. (D) Quantification bar for C. Data represent mean ± SEM; n.s. no significance.
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